{
  "url": "https://www.law.cornell.edu/regulations/new-york/12-NYCRR-800.5",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 12 ยง 800.5 - Permissible exposure limits",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 12 ยง 800.5 - Permissible exposure limits\n\nState Regulations\n\nAn employee 's exposure to any substance listed in Table\nZ-1-A, Z-2, or Z-3 of this section shall be limited in accordance with the\nrequirements of the following paragraphs of this section. (a) TABLE Z-1-A. (1)\n\nSubstances in transitional limits columns\nwith limits preceded by \" C\"-ceiling values. An employee's exposure to any\nsubstance in Table Z-1-A under the transitional limits column, the exposure\nlimit of which is preceded by a \"C\", shall at no time exceed the exposure limit\ngiven for that material in Table Z-1-A under the transitional limits\ncolumns. (2)\n\nOther substances in\ntransitional limits columns-8-hour time weighted average. An employee's\nexposure to any substance in table Z-1-A under the transitional limits columns, the exposure limit of which is not preceded by a \"C\", shall not exceed the\n8-hour time weighted average given for that substance in table Z-1-A under the\ntransitional limits columns in any 8-hour work shift of a 40-hour work\nweek. (3)\n\nFinal rule limits\ncolumns. An employee's exposure to any substance listed in table Z-1-A shall\nnot exceed the time weighted average (TWA), short term exposure limit (STEL), and ceiling limit specified for that substance in table Z-1-A under the final\nlimits columns. (4)\n\nSkin\ndesignation. To prevent or reduce skin absorption, an employee's skin exposure\nto substances listed in table Z-1-A with an \"X\" in one or both of the skin\ndesignation columns following the substance name shall be prevented or reduced\nto the extent necessary in the circumstances through the use of gloves, coveralls, goggles, or other appropriate personal protective equipment, engineering controls or work practices. (5)\n\nDefinitions. The following definitions\nare applicable to the final rule limits columns of table Z-1-A: (i) Time weighted average\n(TWA)\nis the employee's average airborne exposure in any 8-hour work\nshift of a 40-hour work week which shall not be exceeded. (ii)\n\nShort term exposure limit\n(STEL)\nis the employee's 15-minute time weighted average exposure\nwhich shall not be exceeded at any time during a work day unless another time\nlimit is specified in a parenthetical notation below the limit. If another time\nperiod is specified, the time weighted average exposure over that time period\nshall not be exceeded at any time during the working day. (iii)\n\nCeiling\nis the\nemployee's exposure which shall not be exceeded during any part of the work\nday. If instantaneous monitoring is not feasible, then the ceiling shall be\nassessed as a 15-minute time weighted average exposure which shall not be\nexceeded at any time over a working day. (6)\n\nAdditional definition. The terms\nsubstance, air contaminant, and\nmaterial\nare\nequivalent in meaning for 29\nCFR\n1910.1000. ( 29 CFR\n1910\nwas previously\nfiled with the Secretary of State on February 2, 1988, under File Number 240. It is available for inspection at the NYS Department of State and the NYS\nDepartment of Labor, and can be obtained from the U.S. Government Printing\n\nOffice in Federal Register, Volume 52, No. 176, pp. 34460-34578, September 11, 1987). (b) Table\nZ-2. Table Z-2 is applicable for the transitional period and to the\nextent set forth in subdivision (f) of this section. (1)\n\nEight-hour time weighted averages. An\nemployee's exposure to any material listed in table Z-2, in any 8-hour work\nshift of a 40-hour work week, shall not exceed the 8-hour time weighted average\nlimit given for that material in table Z-2. (2)\n\nAcceptable ceiling concentrations. An\nemployee's exposure to a material listed in table Z-2 shall not exceed at any\ntime during an 8-hour shift the acceptable ceiling concentration limit given\nfor the material in the table, except for a time period, and up to a\nconcentration not exceeding the maximum duration and concentration allowed in\nthe column under \"acceptable maximum peak above the acceptable ceiling\nconcentration for an 8-hour shift\". (3)\n\nExample. During an 8-hour work shift, an\nemployee may be exposed to a concentration of Substance A (with a 10 ppm TWA, 25 ppm ceiling and 50 ppm peak) above 25 ppm (but never above 50 ppm) only for\na maximum period of 10 minutes. Such exposure must be compensated by exposures\nto concentrations less than 10 ppm so that the cumulative exposure for the\nentire 8-hour work shift does not exceed a weighted average of 10\nppm. (c) Table\nZ-3. Table Z-3 is applicable for the transitional period and to\nthe extent set forth in subdivision (f) of this section. An employee's exposure\nto any substance listed in table Z-3, in any 8-hour work shift of a 40-hour\nwork week shall not exceed the 8-hour time weighted average limit given for\nthat substance in the table. (d) Computation formulae. The computation formula which shall apply to employee\nexposure to more than one substance for which 8-hour time weighted averages are\nlisted in subpart Z of 29 CFR part\n1910\nin order to determine whether an\nemployee is exposed over the regulatory limit is as follows: (1)\n(i) The\ncumulative exposure for an 8-hour work shift shall be computed as follows: (E = C(a) T(a) + C(b) T(b) +.... C(n) T(n)) divided by\n8\n\nWhere: E is the equivalent exposure for the working shift. C is the concentration during any period of time T where\nthe concentration remains constant. T is the duration in hours of the exposure at the\nconcentration C. The value of E shall not exceed the 8-hour time weighted\naverage specified in Subpart Z or 29 CFR part\n1910\nfor the material\ninvolved. (ii)\n\nTo illustrate\nthe formula prescribed in subparagraph (i) of this paragraph, assume that\n\nSubstance A has an 8-hour time weighted average limit of 100 ppm noted in table\nZ-1-A. Assume than an employee is subject to the following exposure: Substituting this information in the formula, we have\n\nTwo hours exposure at 150 p/m\n\nTwo hours exposure at 75 p/m\n\nFour hours exposure at 50 p/m\n(2 * 150 + 2 * 75 + 4 * 50) divided by 8 = 81.25 p/m\n\nSince 81.25 p.p.m. is less than 100 p.p.m., the 8-hour time\nweighted average limit, the exposure is acceptable. (2)\n(i) In\ncase of a mixture of air contaminants an employer shall compute the equivalent\nexposure as follows: E(m) = (C(1) divided by L(1) + C(2) divided by L(2)) +... (C)(n) divided by L(n))\n\nWhere: E(m) is the equivalent exposure for the mixture. C is the concentration of a particular contaminant. L is the exposure limit for that substance specified in\n\nSubpart Z of 29 CFR part\n1910. The value of E(m) shall not exceed unity (1). (ii)\n\nTo illustrate the formula\nprescribed in subparagraph (d)(2)(i) of this section, consider the following\nexposures: Substance\n\nActual concentration of 8-hour exposure\n(ppm)\n8 hr.TWA PEL (ppm)\nB....... 500\n1,000\nC....... 45\n200\nD....... 40\n200\n\nSubstituting in the formula, we have: E(m) = 500 divided by\n1,000 + 45 divided by 200 + 40 divided by 200 E(m) = 0.500 + 0.225 + 0.200 E(m)\n= 0.925\n\nSince E(m) is less than unity (1), the exposure combination\nis within acceptable limits. (e) To achieve compliance with subdivisions\n(a) through (d) of this section, administrative or engineering controls must\nfirst be determined and implemented whenever feasible. When such controls are\nnot feasible to achieve full compliance, protective equipment or any other\nprotective measures shall be used to keep the exposure of employees to air\ncontaminants within the limits prescribed in this section. Any equipment and/or\ntechnical measures used for this purpose must be approved for each particular\nuse by a competent industrial hygienist or other technically qualified person. Whenever respirators are used, their use shall comply with 1910.134. (f) Effective dates, start-up dates and\ntransitional provisions. (1)\n\nEffective\ndate. The effective date for the permissible exposure limits specified in the\nfinal rule limits columns of table Z-1-A is March 1, 1989. (2)\n(i) The\npermissible exposure limits specified in the final rule columns of table Z-1-A\nshall be achieved by any reasonable combination of engineering controls, work\npractices and personal protective equipment effective September 1, 1989, through December 30, 1992. (See note at end of table Z-1-A). (ii)\n(a) The permissible exposure limits specified in the final rule limits columns of\ntable Z-1-A shall be achieved by the method of compliance specified in\nsubdivision (e) of this section effective December 31, 1992, if by December 31, 1991, a final rule has been published in the Federal Register amending or\ndetermining not to amend subdivision (e) of this section. (b) If no final rule has been published in\nthe Federal Register by December 31, 1991, amending or determining not to amend\nsubdivision (e) of this section, then the permissible limits specified in the\nfinal rule limits columns of table Z-1-A shall be achieved by the methods of\ncompliance specified by subdivision (e) of this section effective December 31, 1993, and subparagraph (f)(2)(i) of this section shall remain in effect through\n\nDecember 30, 1993. (iii)\n\nThe skin designations in the final rule limits columns become effective\n\nSeptember 1, 1989. The skin designations in the transitional limits columns are\nin effect from March 1, 1989, through August 31, 1989. (3)\n\nTransitional provisions. (i) The permissible exposure limits specified\nin the transitional limits columns of table Z-1-A, table Z-2 and table Z-3\nshall continue to be achieved by the methods of compliance specified in\nsubdivision (e) of this section through December 30, 1992. If clause\n(2)(ii)(\nb\n) of this subdivision takes effect, this provision is\nextended through December 30, 1993. The permissible exposure limits specified\nin tables Z-2 and Z-3 for substances mentioned in the final rule limits column\nof table Z-1-A only by cross reference to table Z-2 or Z-3 shall remain in\neffect indefinitely and continue to be achieved by the methods of compliance\nspecified in subdivision (e) of this section. (ii)\n\nThe permissible exposure limits\nspecified in the transitional limits columns of table Z-1-A, Z-2 and Z-3 shall\nbe applicable to the extent cross referenced in 29 CFR parts\n1915, 1917\nand\n1918. (iii)\n\nIf any new or amended\nprovisions or new or revised limits for any substance or substances are either\nadministratively stayed or judicially stayed or vacated, then the existing\nprovisions or limits for those substances specified in the transitional limits\ncolumns of table Z-1-A, table Z-2 or table Z-3 shall remain in effect until\nsuch stay is lifted, or indefinitely, if the limit is vacated. (4)\n\nEnforcement of the limits are\nindefinitely stayed for: aluminum alkyls; ethylidene norbornene; hexafluoracetone; mercury (alkyl compounds); oxygen difluoride; phenylphosphine; and sulfur pentafluoride; until OSHA publishes in the Federal\n\nRegister a notice that a sampling and analytical technique is available. TABLE Z-1-A. LIMITS FOR AIR\nCONTAMINANTS\nNOTE: Footnotes specfic only to a limited\nnumber of substances are also shown within the table. * The transitional PELs are 8-hour TWAs unless otherwise\nnoted; a (C) designation denotes a celing limit. ** Unless otherwise noted, employers in General Industry\n(i.e., those covered by 29 CFR\n1910\n) may use any combination of controls to\nachieve these limits until December 31, 1993 as set forth in\n29 CFR\n1910.1000(f). *** As determined from breathing-zone air samples; a\n\nParts of vapor or gas per\nmillion parts of contaminated air by volume at 25 degrees C and 760\ntorr. b\n\nMilligrams of substance per\ncubic meter of air. When a numerical entry for a substance is in the mg/m(3)\ncolumn and not in the ppm column, then the number in the mg/m(3) is exact. When\nnumerical entries for a substance are in both the ppm and mg/m(3) columns, then\nthe number in the ppm column is exact and the number in the mg/m(3) column may\nbe rounded off. c\n\nDuration is for 15 minutes, unless otherwise noted. d\n\nThe final benzene standard in\n1910.1028 applies to all occupational exposures to benzene except some\nsubsegments of industry where exposures are consistently under the action level\n(i.e., distribution and sale of fuels, sealed containers and pipelines, coke\nproduction, oil and gas drilling and production, natural gas processing, and\nthe percentage exclusion for liquid mixtures); for the excepted subsegment, the\nbenzene limits in table Z-2 apply. e\n\nExposures under 10,000 ppm ato\nbe cited de minimus. f\n\nThe CAS number is for\ninformation only. Enforcement is based on the substance name. For an entry\ncovering more than one metal compound measured as the metal, the CAS number for\nthe metal is given-not CAS numbers for the individual compounds. g\n\nCompliance with the\nsubtilisins PEL is assessed by sampling with a high volume sampler (600-800\nliters per minute) for at least 60 minutes. h\n\nThe Acetone STEL does not\napply to the cellulose acetate fiber industry. It is in effect for all other\nsectors. i\n\nThe final rule limit STEL of 5\nmg/m(3) is not in effect as a result of reconsideration. Calcium hydroxide is\ncovered by the exposure limits for particulates not otherwise regulated of 5\nmg/m(3) respirable dust and 5 mg/m(3) total dust. j\n\nThe final rule limit TWA of 5\nmg/m(3) is not in effect as a result of reconsideration. The calcium oxide\ntransitional limit of 5 mg/m(3) remains in effect and employee exposures shall\nbe kept below that level pursuant to the methods of compliance specified in CFR\n1910.1000(e). k\n\nThe final rule limit STEL of\n0.1 mg/m(3) is not in effect as a result of reconsideration for the industrial\nsector of civilian manufacture and distribution of explosives and propellants\nfor civilian use. The final rule limits skin designation and the transitional\nlimits ceiling limit of 1 mg/m(3) remain in effect for this sector until\ncompletion to the reconsideration. l\n\nThe final rule limit STEL of\n0.1 mg/m(3) is not in effect as a result of reconsideration for the industrial\nsector of civilian manufacture and distribution of explosives and propellants\nfor civilian use. The final rule limits skin designation and the transitional\nlimits ceiling limit of 2 mg/m(3) remain in effect for this sector until\ncompletion of the reconsideration. m\n\nSampling for the carbon\nmonoxide ceiling shall be averaged over 5 minutes but an instantaneous reading\nover 1500 ppm shall not be exceeded. Acetaldehyde\nCAS NO (f): 75-07-0\n\nTransitional Limits: PEL*\n200 ppm(a)\n360 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm (a)\n180 mg/m(3)(b)\nSTEL(c)\n150 ppm (a)\n270 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nAcetetic acid\nCAS NO(f): 64-19-7\n\nTransitional Limits: PEL*\n10 ppm (a)\n25 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm (a)\n25 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nAcetic anhydride\nCAS NO(f): 108-24-7\n\nTransitional Limits: PEL*\n5 ppm(a)\n20 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n5 ppm(a)\n20 mg/m(3)(b)\n\nSkin Designation\n-\nAcetone (h)\nCAS NO(f):67-64-1\n\nTransitional Limits: PEL*\n1000 ppm(a)\n2400 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n750 ppm (a)\n1800 mg/m(3)(b)\nSTEL(c)\n1000 ppm (a) (h)\n2400 mg/m(3)(b) (h)\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (h) The Acetone STEL does not apply to\nthe cellulose acetate fiber industry. It is in effect for all other\nsectors. Acetonitrile*\nCAS NO(f):75-05-8\n\nTransitional Limits: PEL*\n40 ppm(a)\n70 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n40 ppm(a)\n70 mg/m(3)(b)\nSTEL(c)\n60 ppm (a)\n105 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\n2-Acetylaminofluorine; CAS NO(f): 53-96-3\nsee 1910.1014\n\nAcetylene dichloride; see 1, 1-Dichloroethylene\n\nAcetylene tetrabromide\nCAS NO(f):79-27-6\n\nTransitional Limits: PEL*\n1 ppm (a)\n14 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n14 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nAcetylsalicylic acid (Aspirin)\nCAS NO(f):50-78-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nAcrolein\nCAS NO(f):107-02-8\n\nTransitional Limits: PEL*\n0.1 ppm(a)\n0.25 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.25 mg/m(3)(b)\nSTEL(c)\n0.3 ppm(a)\n0.8 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nAcrylamide\nCAS NO(f):79-06-1\n\nTransitional Limits: PEL*\n-\n0.3 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.03 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nAcrylic acid\nCAS NO(f):79-10-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n30 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nAcrylonitrile; CAS NO(f): 107-13-1\nsee 1910.1045\n\nAldrin\nCAS NO(f):309-00-2\n\nTransitional Limits: PEL*\n-\n0.25 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.25 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nAllyl alcohol\nCAS NO(f):107-18-6\n\nTransitional Limits: PEL*\n2 ppm(a)\n5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n2 ppm(a)\n5 mg/m(3)(b)\nSTEL(c)\n4 ppm(a)\n10 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nAllyl chloride\nCAS NO(f):107-05-1\n\nTransitional Limits: PEL*\n1 ppm(a)\n3 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n3 mg/m(3)(b)\nSTEL(c)\n2 ppm(a)\n6 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nAllyl glycidyl ether (AGE)\nCAS NO(f):106-92-3\n\nTransitional Limits: PEL*\n(C) 10 ppm(a)\n(C) 45 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n22 mg/m(3)(b)\nSTEL(c)\n10 ppm(a)\n44 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Allyl propyl disulfide\nCAS NO(f):2179-59-1\n\nTransitional Limits: PEL*\n2 ppm(a)\n12 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n12 mg/m(3)(b)\nSTEL(c)\n3 ppm(a)\n18 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nalpha-Alumina\nCAS NO(f):1344-28-1\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nAluminum (as Al) Metal\nCAS NO (f): 7429-90-5\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPyro Powders\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nWelding Fumes***\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFootnote*** As determined from\nbreathing-zone air samples. Soluble Salts\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nAlkyls\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n4-Aminodiphenyl; CAS NO(f):92-67-1\nsee 1910.1011\n2-Aminoethanol; see Ethanolamine\n2-Aminopyridine\nCAS NO(f):504-29-0\n\nTransitional Limits: PEL*\n0.5 ppm(a)\n2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nAmitrole\nCAS NO(f):61-82-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nAmmonia\nCAS NO(f):7664-41-7\n\nTransitional Limits: PEL*\n50 ppm(a)\n35 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n35 ppm(a)\n27 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nAmmonium chloride fume\nCAS NO(f):12125-02-9\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n20 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nAmmonium sulfamate\nCAS NO(f):7773-06-0\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n20 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nn-Amyl acetate\nCAS NO(f): 628-63-7\n\nTransitional Limits: PEL*\n100 ppm(a)\n525 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n525 mg/m(3)(b)\nSTEL(c)\n20 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nsec-Amyl acetate\nCAS NO(f): 626-38-0\n\nTransitional Limits: PEL*\n125 ppm(a)\n650 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n125 ppm(a)\n650 mg/m(3)(b)\nSTEL(c)\n20 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nAniline and homologs\nCAS NO(f): 62-53-3\n\nTransitional Limits: PEL*\n5 ppm(a)\n19 mg/m(3)(b)\n\nSkin Designation\n2X\nFinal Rule Limits**: TWA\nppm(a)\n8 mg/m(3)(b)\nSTEL(c)\n20 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nAnisidine (o-,p-isomers)\nCAS NO(f):29191-52-4\n\nTransitional Limits: PEL*\n0.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nAntimony and compounds (as Sb)\nCAS NO(f):7440-36-0\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nANTU (alpha Naphthylthiourea)\nCAS NO(f):86-88-4\n\nTransitional Limits: PEL*\n-\n0.3 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.3 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nArsenic, organic compounds (as As)\nCAS NO(f):7440-38-2\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nArsenic, inorganic compounds (as As); see 1910.1018\n\nArsine\nCAS NO(f):7784-42-1\n\nTransitional Limits: PEL*\n0.05 ppm(a)\n0.2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.05 ppm(a)\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nAsbestos\nCAS NO (f): Varies\nsee 1910.1001 and 1910.1101\n\nAtrazine\nCAS NO(f):1912-24-9\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nAzinphos-metyl\nCAS NO(f):86-50-0\n\nTransitional Limits: PEL*\n-\n0.2 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nBarium, soluble compounds (as Ba)\nCAS NO(f):7440-39-3\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nBarium sulfate\nCAS NO(f):7727-43-7\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nBenomyl\nCAS NO(f):17804-35-2\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nBenzene\nCAS NO(f):71-43-2\nsee 1910.1028\n\nSee Table Z-2 for the limits applicable in the\noperations or sectors excluded in 1910.1028(d) Footnote (d) The final benzene\nstandard in 1910.1028 applies to all occupational exposures to benzene except\nsome subsegments of industry where exposures are consistently under the action\nlevel (i.e., distribution and sale of fuels, sealed containers and pipelines, coke production, oil and gas drilling and production, natural gas processing, and the percentage exclusion for liquid mixtures); for the excepted\nsubsegments, the benzene limits in Table Z-2 apply. Benzidine\nCAS NO(f):92-87-5\nsee 1910.1010\np-Benzoquinone; see Quinone\n\nBenzo (a) pyrene; see Coal tar pitch volatiles\n\nBenzoyl peroxide\nCAS NO(f):94-36-0\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nBenzyl chloride\nCAS NO(f):100-44-7\n\nTransitional Limits: PEL*\n1 ppm(a)\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nBeryllium and beryllium compounds\n(as Be)\nCAS NO(f):7440-41-7\n\nTransitional Limits: PEL*\nTbl. Z-2\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\nTbl. Z-2\n\nTbl. Z-2\nSTEL(c)\n\nTbl. Z-2\nCEILING\n-\n-\nSkin Designation\n-\nBiphenyl; see Diphenyl\n\nBismuth telluride, Undoped\nCAS NO(f):1304-82-1\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nBismuth telluride, Se-doped\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nBorates, tetra, sodium salts\n\nAnhydrous\nCAS NO (f): 1330-43-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDecahydrate\nCAS NO(f):1303-96-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m (3) (b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPentahydrate\nCAS NO(f):12179-04-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nBoron oxide\nCAS NO(f):1303-86-2\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nBoron tribromide\nCAS NO(f):10294-33-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n1 ppm(a)\n10 mg/m(3)(b)\n\nSkin Designation\n-\nBoron trifluoride\nCAS NO(f):7637-07-2\n\nTransitional Limits: PEL*\n(C) 1 ppm(a)\n(C) 3 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n1 ppm(a)\n3 mg/m(3)(b)\n\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Bromacil\nCAS NO(f):314-40-9\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nBromine\nCAS NO(f):7726-95-6\n\nTransitional Limits: PEL*\n0.1 ppm(a)\n0.7 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.7 mg/m(3)(b)\nSTEL(c)\n0.3 ppm(a)\n2 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nBromine pentafluoride\nCAS NO(f):7789-30-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.7 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nBromoform\nCAS NO(f):75-25-2\n\nTransitional Limits: PEL*\n0.5 ppm(a)\n5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nButadiene (1,3-Butadiene)\nCAS NO(f):106-99-0\n\nTransitional Limits: PEL*\n1000 ppm(a)\n2200 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n2200 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nButane\nCAS NO(f):106-97-8\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n800 ppm(a)\n1900 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nButanethiol; see Butyl mercaptan\n2-Butanone (Methyl ethyl ketone)\nCAS NO(f):78-93-3\n\nTransitional Limits: PEL*\n200 ppm(a)\n590 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n590 mg/m(3)(b)\nSTEL(c)\n300 ppm(a)\n885 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\n2-Butoxyethanol\nCAS NO(f):111-76-2\n\nTransitional Limits: PEL*\n50 ppm(a)\n240 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n25 ppm(a)\n120 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nn-Butyl-acetate\nCAS NO(f):123-86-4\n\nTransitional Limits: PEL*\n150 ppm(a)\n710 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n150 ppm(a)\n710 mg/m(3)(b)\nSTEL(c)\n200 ppm(a)\n950 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nsec-Butyl acetate\nCAS NO(f):105-46-4\n\nTransitional Limits: PEL*\n200 ppm(a)\n950 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n950 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\ntert-Butyl-acetate\nCAS NO(f):540-88-5\n\nTransitional Limits: PEL*\n200 ppm(a)\n950 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm (a)\n950 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nButyl acrylate\nCAS NO(f):141-32-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n55 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nn-Butyl alcohol\nCAS NO(f):71-36-3\n\nTransitional Limits: PEL*\n100 ppm(a)\n300 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n50 ppm(a)\n150 mg/m(3)(b)\n\nSkin Designation\nX\nsec-Butyl alcohol\nCAS NO(f):78-92-2\n\nTransitional Limits: PEL*\n150 ppm(a)\n450 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n305 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\ntert-Butyl alcohol\nCAS NO(f):75-65-0\n\nTransitional Limits: PEL*\n100 ppm(a)\n300 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n300 mg/m(3)(b)\nSTEL(c)\n150 ppm(a)\n450 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nButylamine\nCAS NO (f): 109-73-9\n\nTransitional Limits: PEL*\n(C) 5 ppm(a)\n(C) 15 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n5 ppm(a)\n15 mg/m(3)(b)\n\nSkin Designation\nX\nFootnote (C) denotes a ceiling\nlimit. tert-Butyl chromate (as CrO (3))\nCAS NO(f):1189-85-1\n\nTransitional Limits: PEL*\n-\n(C) 0.1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.1 mg/m(3)(b)\n\nSkin Designation\nX\nFootnote (C) denotes a ceiling\nlimit. n-Butyl glycidyl ether (BGE)\nCAS NO(f):2426-08-6\n\nTransitional Limits: PEL*\n50 ppm(a)\n270 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n25 ppm(a)\n135 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nn-Butyl lactate\nCAS NO(f):138-22-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n25 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nButyl mercaptan\nCAS NO(f):109-79-5\n\nTransitional Limits: PEL*\n10 ppm(a)\n35 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n1.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\no-sec-Butylphenol\nCAS NO(f):89-72-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n30 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\np-tert-Butyltoluene\nCAS NO(f):98-51-1\n\nTransitional Limits: PEL*\n10 ppm(a)\n60 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n60 mg/m(3)(b)\nSTEL(c)\n20 ppm(a)\n120 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\n* Cadmium fume (as Cd)\nCAS NO(f): 7440-43-9\n(This entire line has been replaced per\n57 FR\n42388, Sept. 14, 1992 by the following): Cadmium; see 1910.1027. See Table Z-2\nfor the exposure limits for any operations or sectors where the exposure limits\nin 1910.1027 are stayed or otherwise not in effect. Cadmium dust (as Cd)\nCAS NO(f): 7440-43-9\n(This entire line has been replaced per\n57 FR\n42388, Sept. 14, 1992 by the following): Cadmium; see 1910.1027. See Table Z-2\nfor the exposure limits for any operations or sectors where the exposure limits\nin 1910.1027 are stayed or otherwise not in effect. Calcium Carbonate\nCAS NO(f):1317-65-3\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCalcium cyanamide\nCAS NO(f):156-62-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCalcium hydroxide (i)\nCAS NO(f):1305-62-0\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)(i)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (i) The Final Rule Limit of 5\nmg/m(3) is not in effect as a result of reconsideration. Calcium hydroxide is covered by the\nexposure limits for particulates not otherwise regulated of 5 mg/m(3)\nrespirable dust and 5 mg/m(3) total dust. Calcium oxide (j)\nCAS NO(f):1305-78-8\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)(j)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (j) The Final Rule Limit TWA of\n5 mg/m(3) is not in effect as a result of reconsideration. The calcium oxide Transitional Limit of 5\nmg/m(3) remains in effect and employee exposures shall be kept below that level\npursuant to the methods of compliance specified in\n29 CFR\n1910.1000(e). Calcium Silicate\nCAS NO(f):1344-95-2\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCalcium sulfate\nCAS NO(f):7778-18-9\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCamphor, synthetic\nCAS NO(f):76-22-2\n\nTransitional Limits: PEL*\n-\n2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCaprolactam\nCAS NO(f):105-60-2\n\nDust\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n3 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nVapor\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n20 mg/m(3)(b)\nSTEL(c)\n10 ppm(a)\n40 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nCaptafol (Difolatan (R))\nCAS NO(f): 2425-06-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCaptan\nCAS NO(f): 133-06-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCarbaryl (Sevin (R))\nCAS NO(f): 63-25-2\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCarbofuran (Furadan (R))\nCAS NO(f): 1563-66-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCarbon black\nCAS NO(f): 1333-86-4\n\nTransitional Limits: PEL*\n-\n3.5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n3.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCarbon dioxide\nCAS NO(f): 124-38-9\n\nTransitional Limits: PEL*\n5000(e) ppm(a)\n9,000 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10,000 ppm(a)\n18,000 mg/m(3)(b)\nSTEL(c)\n30,000 ppm(a)\n54,000 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (e) Exposures under 10,000 ppm\nto be cited de minimus. Carbon disulfide\nCAS NO(f): 75-15-0\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nFinal Rule Limits**: TWA\n4 ppm(a)\n12 mg/m(3)(b)\nSTEL(c)\n12 ppm(a)\n36 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nCarbon monoxide\nCAS NO(f): 630-08-0\n\nTransitional Limits: PEL*\n50 ppm(a)\n55 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n35 ppm(a)\n40 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n200 ppm(a)(m)\n229 mg/m(3)(b)(m)\n\nSkin Designation\n-\nNote: Stayed CEILING for blast furnace\noperations, vessel blowing at basic oxygen furnaces and sinter plants in the\nsteel industry (SIC 33), termination pending (FR 55: 3724, 2/5/90)\n\nFootnote (m) Sampling for the carbon\nmonoxide ceiling shall be averaged over 5 minutes but an instantaneous reading\nover 1500 ppm shall not be exceeded. Carbon tetrabromide\nCAS NO(f): 558-13-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n1.4 mg/m(3)(b)\nSTEL(c)\n0.3 ppm(a)\n4 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nCarbon tetrachloride\nCAS NO(f): 56-23-5\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n12.6 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCarbonyl fluoride\nCAS NO(f): 353-50-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n5 mg/m(3)(b)\nSTEL(c)\n5 ppm(a)\n15 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nCatechol (Pyrocatechol)\nCAS NO(f): 120-80-9\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n20 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nCellulose\nCAS NO(f): 9004-34-6\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCesium hydroxide\nCAS NO(f): 21351-79-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nChlordane\nCAS NO(f): 57-74-9\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nChlorinated camphene\nCAS NO(f): 8001-35-2\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n1 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nChlorinated diphenyl oxide\nCAS NO(f): 55720-99-5\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nChlorine\nCAS NO(f): 7782-50-5\n\nTransitional Limits: PEL*\n(C) 1 ppm(a)\n(C) 3 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n1.5 mg/m(3)(b)\nSTEL(c)\n1 ppm(a)\n3 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Chlorine dioxide\nCAS NO(f): 10049-04-4\n\nTransitional Limits: PEL*\n0.1 ppm(a)\n0.3 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.3 mg/m(3)(b)\nSTEL(c)\n0.3 ppm(a)\n0.9 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nChlorine trifluoride\nCAS NO(f): 7790-91-2\n\nTransitional Limits: PEL*\n(C) 0.1 ppm(a)\n(C) 0.4 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.1 ppm(a)\n0.4 mg/m(3)(b)\n\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Chloroacetaldehyde\nCAS NO(f): 107-20-0\n\nTransitional Limits: PEL*\n(C) 1 ppm(a)\n(C) 3 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n1 ppm(a)\n3 mg/m(3)(b)\n\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. a-Chloroacetophenone (Phenacyl\nchloride)\nCAS NO(f): 532-27-4\n\nTransitional Limits: PEL*\n0.05 ppm(a)\n0.3 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.05 ppm(a)\n0.3 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nChloroacetyl chloride\nCAS NO(f): 79-04-9\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.05 ppm(a)\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nChlorobenzene\nCAS NO(f): 108-90-7\n\nTransitional Limits: PEL*\n75 ppm(a)\n350 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n75 ppm(a)\n350 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\no-Chlorobenzylidene malononitrile\nCAS NO(f): 2698-41-1\n\nTransitional Limits: PEL*\n0.05 ppm(a)\n0.4 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.05 ppm(a)\n0.4 mg/m(3)(b)\n\nSkin Designation\nX\nChlorobromomethane\nCAS NO(f): 74-97-5\n\nTransitional Limits: PEL*\n200 ppm(a)\n1050 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n1050 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n2-Chloro-1,3-butadiene; see b-Chloroprene\n\nChlorodifluoromethane\nCAS NO(f): 75-45-6\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n3500 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nChlorodiphenyl (42% Chlorine) (PCB)\nCAS NO(f): 53469-21-9\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nChlorodiphenyl (54% Chlorine) (PCB)\nCAS NO(f): 11097-69-1\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\n1-Chloro, 2,3-epoxypropane; see Epichlorohydrin\n2-Chloroethanol; see Ethylene chlorohydrin\n\nChloroethylene; see Vinyl chloride\n\nChloroform (Trichloromethane)\nCAS NO(f): 67-66-3\n\nTransitional Limits: PEL*\n(C) 50 ppm(a)\n(C) 240 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n9.78 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. bis (Chloromethyl) ether\nCAS NO(f): 542-88-1\nsee 1910.1008\n\nChloromethyl methyl ether\nCAS NO(f): 107-30-2\nsee 1910.1006\n1-Chloro-1-nitropropane\nCAS NO(f): 600-25-9\n\nTransitional Limits: PEL*\n20 ppm(a)\n100 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nChloropentafluoroethane\nCAS NO(f): 76-15-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n6320 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nChloropicrin\nCAS NO(f): 76-06-2\n\nTransitional Limits: PEL*\n0.1 ppm(a)\n0.7 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.7 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nbeta-Chloroprene\nCAS NO(f): 126-99-8\n\nTransitional Limits: PEL*\n25 ppm(a)\n90 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n10 ppm(a)\n35 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\no-Chlorostyrene\nCAS NO(f): 2039-87-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n285 mg/m(3)(b)\nSTEL(c)\n75 ppm(a)\n428 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\no-Chlorotoluene\nCAS NO(f): 95-49-8\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n250 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n2-Chloro-6-trichloro-methyl pyridine\nCAS NO(f): 1929-82-4\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nChlorpyrifos\nCAS NO(f): 2921-88-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nChromic acid and chromates (as CrO\n(3))\nCAS NO(f): 7440-47-3\n\nTransitional Limits: PEL*\n-\nTbl. Z-2\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.1 ppm(a)\n\nSkin Designation\n-\n* Chromium (II) compounds (as Cr)\nCAS NO(f): 7440-47-3\n(This entry removed by 57 FR\n29205, July\n1, 1992)\n\nChromium, Sol. chromic, chromous salts (as\n\nCr)\nCAS NO(f): 7440-47-3\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nChromium, metal and soluble salts\nCAS NO(f): 7440-47-3\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nChrysene: see Coal tar pitch volatiles\n\nClopidol\nCAS NO(f): 2971-90-6\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCoal dust (Less than 5% SiO (2))\n\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n9 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCoal dust (Greater than or equal to 5% SiO\n(2))\n\nRespirable quartz fraction\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCoal tar pitch volatiles\nCAS NO(f): 65996-93-2\n(Benzine soluble fraction), Anthracene, BaP, Phenanthrene, Acridine, Chrysene, Pyrene\n\nTransitional Limits: PEL*\n-\n0.2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCobalt metal, dust, and fume (as Co)\nCAS NO(f): 7440-48-4\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.05 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCobalt carbonyl (as Co)\nCAS NO(f): 10210-68-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCobalt hydrocarbonyl (as Co)\nCAS NO(f): 16842-03-8\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCoke oven emissions; see 1910.1029\n\nCopper\nCAS NO(f): 7440-50-8\n\nFume (as Cu)\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDusts and mists (as Cu)\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCotton dust (Raw)\n\nTransitional Limits: PEL*\n1 mg/m(3)(b)\nTWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nThis 8-hour TWA applies to respirable\ndust as measured by a vertical elutriator cotton dust sampler or equivalent\ninstrument. The time-weighted average applies to the cotton waste processing\noperations of waste recycling (sorting, blending, cleaning, and willowing) and\ngarnetting. See also 1910.1043 for cotton dust limits applicable to other\nsectors. Crag herbicide (Sesone)\nCAS NO(f): 136-78-7\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCresol, all isomers\nCAS NO(f): 1319-77-3\n\nTransitional Limits: PEL*\n5 ppm(a)\n22 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n5 ppm(a)\n22 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nCrotonaldehyde\nCAS NO(f): 123-73-9; 4170-30-3\n\nTransitional Limits: PEL*\n2 ppm(a)\n6 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n6 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCrufomate\nCAS NO(f): 299-86-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCumene\nCAS NO(f): 98-82-8\n\nTransitional Limits: PEL*\n50 ppm(a)\n245 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n50 ppm(a)\n245 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nCyanamide\nCAS NO(f): 420-04-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCyanides (as CN)\nCAS NO(f): Varies With Compound\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCyanogen\nCAS NO(f): 460-19-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n20 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCyanogen chloride\nCAS NO(f): 506-77-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.3 ppm(a)\n0.6 mg/m(3)(b)\n\nSkin Designation\n-\nCyclohexane\nCAS NO(f): 110-82-7\n\nTransitional Limits: PEL*\n300 ppm(a)\n1050 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n300 ppm(a)\n1050 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCyclohexanol\nCAS NO(f): 108-93-0\n\nTransitional Limits: PEL*\n50 ppm(a)\n200 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n200 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nCyclohexanone\nCAS NO(f): 108-94-1\n\nTransitional Limits: PEL*\n50 ppm(a)\n200 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n25 ppm(a)\n100 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nCyclohexene\nCAS NO(f): 110-83-8\n\nTransitional Limits: PEL*\n300 ppm(a)\n1015 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n300 ppm(a)\n1015 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCyclohexylamine\nCAS NO(f): 108-91-8\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n40 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCyclonite\nCAS NO(f): 121-82-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nCyclopentadiene\nCAS NO(f): 542-92-7\n\nTransitional Limits: PEL*\n75 ppm(a)\n200 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n75 ppm(a)\n200 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCyclopentane\nCAS NO(f): 287-92-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n600 ppm(a)\n1720 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nCyhexatin\nCAS NO(f): 13121-70-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n* 2,4-D (Dichlorophenoxyacetic acid)\nCAS NO(f): 94-75-7\n\nTransitional Limits: PEL*\n-\n10 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDecaborane\nCAS NO(f): 17702-41-9\n\nTransitional Limits: PEL*\n0.05 ppm(a)\n0.3 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n0.05 ppm(a)\n0.3 mg/m(3)(b)\nSTEL(c)\n0.15 ppm(a)\n0.9 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nDemeton (Systox (R))\nCAS NO(f): 8065-48-3\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDichlorodiphenyltrichloroethane\n(DDT)\nCAS NO(f): 50-29-3\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDichlorvos (DDVP)\nCAS NO(f): 62-73-7\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDiacetone alcohol\n(4-Hydroxy-4-methyl-2-pentanone)\nCAS NO(f): 123-42-2\n\nTransitional Limits: PEL*\n50 ppm(a)\n240 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n240 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n1,2-Diaminoethane; see Ethylenediamine\n\nDiazinon\nCAS NO(f): 333-41-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDiazomethane\nCAS NO(f): 334-88-3\n\nTransitional Limits: PEL*\n0.2 ppm(a)\n0.4 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.2 ppm(a)\n0.4 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDiborane\nCAS NO(f): 19287-45-7\n\nTransitional Limits: PEL*\n0.1 ppm(a)\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n1,2-Dibromo-3-chloropropane\nCAS NO(f): 96-12-8\nsee 1910.1044\n2-N-Dibutylaminoethanol\nCAS NO(f): 102-81-8\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n14 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDibutyl phosphate\nCAS NO(f): 107-66-4\n\nTransitional Limits: PEL*\n1 ppm(a)\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n5 mg/m(3)(b)\nSTEL(c)\n2 ppm(a)\n10 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nDibutyl phthalate\nCAS NO(f): 84-74-2\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDichloroacetylene\nCAS NO(f): 7572-29-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.1 ppm(a)\n0.4 mg/m(3)(b)\n\nSkin Designation\n-\no-Dichlorobenzene\nCAS NO(f): 95-50-1\n\nTransitional Limits: PEL*\n(C) 50 ppm(a)\n(C) 300 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n50 ppm(a)\n300 mg/m(3)(b)\n\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. p-DICHLOROBENZENE\nCAS NO(f): 106-46-7\n\nTransitional Limits: PEL*\n75 ppm(a)\n450 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n75 ppm(a)\n450 mg/m(3)(b)\nSTEL(c)\n110 ppm(a)\n675 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\n3,32 -Dichlorobenzidine; CAS NO(f): 91-94-1\nsee 1910.1007\n\nDichlorodifluoro-methane\nCAS NO(f): 75-71-8\n\nTransitional Limits: PEL*\n1000 ppm(a)\n4950 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n4950 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n1,3-Dichloro-5,5-dimethyl hydantoin\nCAS NO(f): 118-52-5\n\nTransitional Limits: PEL*\n-\n0.2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n0.4 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\n1,1-Dichloroethane\nCAS NO(f): 75-34-3\n\nTransitional Limits: PEL*\n100 ppm(a)\n400 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n400 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n1,2-Dichloroethylene\nCAS NO(f): 540-59-0\n\nTransitional Limits: PEL*\n200 ppm(a)\n790 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n790 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDichlorethyl ether\nCAS NO(f): 111-44-4\n\nTransitional Limits: PEL*\n(C) 15 ppm(a)\n(C) 90 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n5 ppm(a)\n30 mg/m(3)(b)\nSTEL(c)\n10 ppm(a)\n60 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nFootnote (C) denotes a ceiling\nlimit. Dichloromethane; see Methylene\nchloride\n\nDichloromonofluoro-methane\nCAS NO(f): 75-43-4\n\nTransitional Limits: PEL*\n1000 ppm(a)\n4200 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n40 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n1,1-Dichloro-1-nitroethane\nCAS NO(f): 594-72-9\n\nTransitional Limits: PEL*\n(C) 10 ppm(a)\n(C) 60 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n\nFootnote (C) denotes a ceiling\nlimit. 1,2-Dichloropropane; see Propylenedichloride\n1,3-Dichloropropene\nCAS NO(f): 542-75-6\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\n2,2-Dichloropropionic acid\nCAS NO(f): 75-99-0\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n6 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDichlorotetrafluoroethane\nCAS NO(f): 76-14-2\n\nTransitional Limits: PEL*\n1000 ppm(a)\n7000 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n7000 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDicrotophos\nCAS NO(f): 141-66-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.25 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDicyclopentadiene\nCAS NO(f): 77-73-6\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n30 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDicyclopentadienyl iron\nCAS NO(f): 102-54-5\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n\nDieldrin\nCAS NO(f): 60-57-1\n\nTransitional Limits: PEL*\n0.25 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-.025 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDiethanolamine\nCAS NO(f): 111-42-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n3 ppm(a)\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDiethylamine\nCAS NO(f): 109-89-7\n\nTransitional Limits: PEL*\n25 ppm(a)\n75 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n30 mg/m(3)(b)\nSTEL(c)\n25 ppm(a)\n75 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\n2-Diethylaminoethanol\nCAB NO(f): 100-37-8\n\nTransitional Limits: PEL*\n10 ppm(a)\n50 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n10 ppm(a)\n50 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDiethylene triamine\nCAS NO(f): 111-40-0\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n4 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDiethyl ether; see Ethyl ether\n\nDiethyl ketone\nCAS NO(f): 96-22-0\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n705 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDiethyl phthalate\nCAS NO(f): 84-66-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDifluorodibromomethane\nCAS NO(f): 75-61-6\n\nTransitional Limits: PEL*\n100 ppm(a)\n860 mg/m(3)(b)\n\nSkin Designation\n\nFinal Rule Limits**: TWA\n100 ppm(a)\n860 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDiglycidyl ether (DGE)\nCAS NO(f): 2238-07-5\n\nTransitional Limits: PEL*\n(C) 0.5 ppm(a)\n(C) 2.8 mg/m(3)(b)\n\nSkin Designation\n\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Dihydroxybenzene; see Hydroquinone\n\nDiisobutyl ketone\nCAS NO(f): 108-83-8\n\nTransitional Limits: PEL*\n50 ppm(a)\n290 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n25 ppm(a)\n150 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDiisopropylamine\nCAS NO(f): 108-18-9\n\nTransitional Limits: PEL*\n5 ppm(a)\n20 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n5 ppm(a)\n20 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\n4-Dimethylaminoazobenzene; CAS NO(f): 60-11-7\nsee 1910.1015\n\nDimethoxymethane; see Methylal\n\nDimethyl acetamide\nCAS NO(f): 127-19-5\n\nTransitional Limits: PEL*\n10 ppm(a)\n35 mg/m(3)(b)\n\nSkin Designation\n\nFinal Rule Limits**: TWA\n10 ppm(a)\n35 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDimethylamine\nCAS NO(f): 124-40-3\n\nTransitional Limits: PEL*\n10 ppm(a)\n18 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n18 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDimethylaminobenzene; see Xylidine\n* Dimethylaniline\n(N,N-Dimethylaniline)\nCAS NO(f): 121-69-7\n\nTransitional Limits: PEL*\n5 ppm(a)\n25 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n5 ppm(a)\n25 mg/m(3)(b)\nSTEL(c)\n10 ppm(a)\n50 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nDimethylbenzene; see Xylene\n\nDimethyl-1,2-dibromo-2,2-dichloroethyl\nphosphate\nCAS NO(f): 300-76-5\n\nTransitional Limits: PEL*\n-\n3 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n3 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDimethyloformamide\nCAS NO(f): 68-12-2\n\nTransitional Limits: PEL*\n10 ppm(a)\n30 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n10 ppm(a)\n30 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\n2,6-Dimethyl-4-hepta-none; see Diisobutyl ketone\n1,1-Dimethylhydrazine\nCAS NO(f): 57-14-7\n\nTransitional Limits: PEL*\n0.5 ppm(a)\n1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDimethylphthalate\nCAS NO(f): 131-11-3\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDimethyl sulfate\nCAS NO(f): 77-78-1\n\nTransitional Limits: PEL*\n1 ppm(a)\n5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDinitolmide (3,5-Dinitro-o-toluamide)\nCAS NO(f): 148-01-6\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDinitrobenzene (all isomers)\nCAS NO(f): (alpha-) 528-29-0; (meta-) 99-65-0; (para-) 100-25-4\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDinitro-o-cresol\nCAS NO(f): 534-52-1\n\nTransitional Limits: PEL*\n-\n0.2 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDinitrotoluene\nCAS NO(f): 25321-14-6\n\nTransitional Limits: PEL*\n-\n1.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n1.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDioxane (Diethylene dioxide)\nCAS NO(f): 123-91-1\n\nTransitional Limits: PEL*\n100 ppm(a)\n360 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n25 ppm(a)\n90 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDioxathion (Delnav)\nCAS NO(f): 78-34-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nDiphenyl (Biphenyl)\nCAS NO(f): 92-52-4\n\nTransitional Limits: PEL*\n0.2 ppm(a)\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.2 ppm(a)\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDiphenylamine\nCAS NO(f): 122-39-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDiphenylmethane diisocyanate; see Methylene bisphenyl isocyanate\n\nDipropylene glycol methyl ether\nCAS NO(f): 34590-94-8\n\nTransitional Limits: PEL*\n100 ppm(a)\n600 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n100 ppm(a)\n600 mg/m(3)(b)\nSTEL(c)\n150 ppm(a)\n900 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nDipropyl ketone\nCAS NO(f): 123-19-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n235 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDiquat\nCAS NO(f): 86-00-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDi-sec octyl phthalate\n(Di-2-ethylhexyl-phthalate)\nCAS NO(f): 117-81-7\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n10 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nDisulfiram\nCAS NO(f): 97-77-8\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDisulfoton\nCAS NO(f): 298-04-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\n2,6-Di-tert-butyl-p-cresol\nCAS NO(f): 128-37-0\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDiuron\nCAS NO(f): 330-54-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nDivinyl benzene\nCAS NO(f): 1321-74-0\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n50 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n* Emery\nCAS NO(f): 12415-34-8\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nEndosulfan\nCAS NO(f): 115-29-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nEndrin\nCAS NO(f): 72-20-8\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nEpichlorohydrin\nCAS NO(f): 106-89-8\n\nTransitional Limits: PEL*\n5 ppm(a)\n19 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n2 ppm(a)\n8 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nEPN\nCAS NO(f): 2104-64-5\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\n1,2-Epoxypropane; see Propylene oxide\n2,3-Epoxy-1-propanol; see Glycidol\n\nEthanethiol; see Ethyl mercaptan\n\nEthanolamine\nCAS NO(f): 141-43-5\n\nTransitional Limits: PEL*\n3 ppm(a)\n6 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n3 ppm(a)\n8 mg/m(3)(b)\nSTEL(c)\n6 ppm(a)\n15 m/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nEthion\nCAS NO(f): 563-12-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.4 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\n2-Ethoxyethanol\nCAS NO(f): 110-80-5\n\nTransitional Limits: PEL*\n200 ppm(a)\n740 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n200 ppm(a)\n740 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\n2-Ethoxyethyl acetate (Cellosolve\nacetate)\nCAS NO(f): 111-15-9\n\nTransitional Limits: PEL*\n100 ppm(a)\n540 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n100 ppm(a)\n540 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nEthyl acetate\nCAS NO(f): 141-78-6\n\nTransitional Limits: PEL*\n400 ppm(a)\n1400 mg/m(3)(b)\n\nSkin Designation\n\nFinal Rule Limits**: TWA\n400 ppm(a)\n1400 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nEthyl acrylate\nCAS NO(f): 140-88-5\n\nTransitional Limits: PEL*\n25 ppm(a)\n100 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n5 ppm(a)\n20 mg/m(3)(b)\nSTEL(c)\n25 ppm(a)\n100 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nEthyl alcohol (Ethanol)\nCAS NO(f): 64-17-5\n\nTransitional Limits: PEL*\n1000 ppm(a)\n1900 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n1900 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nEthylamine\nCAS NO(f): 75-04-7\n\nTransitional Limits: PEL*\n10 ppm(a)\n18 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n18 mg/m(3)(b)\nSTEL\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nEthyl amyl ketone\n(5-Methyl-3-heptanone)\nCAS NO(f): 541-85-5\n\nTransitional Limits: PEL*\n25 ppm(a)\n130 mg/m(3)(b)\n\nSkin Designation\n\nFinal Rule Limits**: TWA\n25 ppm(a)\n130 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nEthyl benzene\nCAS NO(f): 100-41-4\n\nTransitional Limits: PEL*\n100 ppm(a)\n435 mg/m(3)(b)\n\nSkin Designation\n\nFinal Rule Limits**: TWA\n100 ppm(a)\n435 mg/m(3)(b)\nSTEL(c)\n125 ppm(a)\n545 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nEthyl bromide\nCAS NO(f): 74-96-4\n\nTransitional Limits: PEL*\n200 ppm(a)\n890 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n890 mg/m(3)(b)\nSTEL(c)\n250 ppm(a)\n1110 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nEthyl butyl ketone (3-Heptanone)\nCAS NO(f): 106-35-4\n\nTransitional Limits: PEL*\n50 ppm(a)\n230 mg/m(3)(b)\n\nSkin Designation\n\nFinal Rule Limits**: TWA\n50 ppm(a)\n230 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nEthyl chloride\nCAS NO(f): 75-003\n\nTransitional Limits: PEL*\n1000 ppm(a)\n2600 mg/m(3)(b)\n\nSkin Designation\n\nFinal Rule Limits**: TWA\n1000 ppm(a)\n2600 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nEthyl ether\nCAS NO(f): 60-29-7\n\nTransitional Limits: PEL*\n400 ppm(a)\n1200 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n400 ppm(a)\n1200 mg/m(3)(b)\nSTEL(c)\n500 ppm(a)\n1500 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nEthyl formate\nCAS NO(f): 109-94-4\n\nTransitional Limits: PEL*\n100 ppm(a)\n300 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n300 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nEthyl mercaptan\nCAS NO(f): 75-08-1\n\nTransitional Limits: PEL*\n(C) 10 ppm(a)\n(C) 25 mg/m(3)(b)\n\nSkin Designation\n\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Ethyl silicate\nCAS NO(f): 78-10-4\n\nTransitional Limits: PEL*\n100 ppm(a)\n850 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n85 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nEthylene chlorohydrin\nCAS NO(f): 107-07-3\n\nTransitional Limits: PEL*\n5 ppm(a)\n16 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n1 ppm(a)\n3 mg/m(3)(b)\n\nSkin Designation\nX\nEthylenediamine\nCAS NO(f): 107-15-3\n\nTransitional Limits: PEL*\n10 ppm(a)\n25 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n25 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nEthylene dibromide\nCAS NO(f): 106-93-4\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nTbl. Z-2\n\nSkin Designation\n\nTbl. Z-2\n\nFinal Rule Limits**: TWA\nSTEL(c)\n\nTbl. Z-2\n\nTbl. Z-2\nCEILING\nTbl. Z-2\n\nTbl. Z-2\n\nSkin Designation\n\nTbl. Z-2\n\nEthylene Dichloride\nCAS NO(f): 107-06-2\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nTbl. Z-2\n\nSkin Designation\n\nTbl. Z-2\n\nFinal Rule Limits**: TWA\n1 ppm(a)\n4 mg/m(3)(b)\nSTEL(c)\n2 ppm(a)\n8 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nEthylene glycol\nCAS NO(f): 107-21-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n50 ppm(a)\n125 mg/m(3)(b)\n\nSkin Designation\n-\nEthylene glycol dinitrate(k)\nCAS NO(f): 628-96-6\n\nTransitional Limits: PEL*\n(C) 0.2 ppm(a)\n(C) 1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n0.1 mg/m(3)(b)(k)\nCEILING\n-\n-\nSkin Designation\nX\nFootnote (C) denotes a ceiling\nlimit. Footnote (k) The Final Rule Limit STEL\nof 0.1 mg/m(3) is not in effect as a result of reconsideration for the\nindustrial sector of civilian manufacture and distribution of explosives and\npropellants for civilian use. The Final rule limits skin designation and the\n\nTransitional limits ceiling limit of 1 mg/ m(3) remain in effect for this\nsector until completion of the reconsideration. Ethylene glycol methyl acetate; see Methyl cellosolve accetate\n\nEthyleneimine; CAS NO(f): 151-56-4\nsee 1910.1012\n\nEthylene oxide; CAS NO(f): 75-21-8\nsee 1910.1047\n\nEthylidene chloride; see 1,1-Dichlorethane\n\nEthylidene norbornene\nCAS NO(f): 16219-75-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n5 ppm(a)\n25 mg/m(3)(b)\n\nSkin Designation\n-\nN-Ethylmorpholine\nCAS NO(f): 100-74-3\n\nTransitional Limits: PEL*\n20 ppm(a)\n94 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n5 ppm(a)\n23 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nFenamiphos\nCAS NO(f): 22224-92-6\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nFensulfothion (Dasanit)\nCAS NO(f): 115-90-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFenthion\nCAS NO(f): 55-38-9\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nFerbam\nCAS NO(f): 14484-64-1\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFerrovanadium dust\nCAS NO(f): 12604-58-9\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL\n-\n3 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nFluorides (as F)\nCAS NO(f): Varies with Compound\n\nTransitional Limits: PEL*\n-\n2.5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFluorine\nCAS NO(f): 77821-41-4\n\nTransitional Limits: PEL*\n0.1 ppm(a)\n0.2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFluorotrichloro-methane\n(Trichloro-fluoromethane)\nCAS NO(f): 75-69-4\n\nTransitional Limits: PEL*\n1000 ppm(a)\n5600 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n1000 ppm(a)\n5600 mg/m(3)(b)\n\nSkin Designation\n-\nFononfos\nCAS NO(f): 944-22-9\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\n* Formaldehyde; CAS NO(f): 50-00-0\nsee 1910.1048\n\nFormamide\nCAS NO(f): 75-12-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n20 ppm(a)\n30 mg/m(3)(b)\nSTEL(c)\n30 ppm(a)\n45 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nFormic acid\nCAS NO(f): 64-18-6\n\nTransitional Limits: PEL*\n5 ppm(a)\n9 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n9 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFurfural\nCAS NO(f): 98-01-1\n\nTransitional Limits: PEL*\n5 ppm(a)\n20 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n2 ppm(a)\n8 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nFurfuryl alcohol\nCAS NO(f): 98-00-0\n\nTransitional Limits: PEL*\n50 ppm(a)\n200 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n40 mg/m(3)(b)\nSTEL(c)\n15 ppm(a)\n60 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nGasoline\nCAS NO(f): 8006-61-9\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n300 ppm(a)\n900 mg/m(3)(b)\nSTEL(c)\n500 ppm(a)\n1500 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nGermanium tetrahydride\nCAS NO(f): 7782-65-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.2 ppm(a)\n0.6 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nGlutaraldehyde\nCAS NO(f): 111-30-8\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.2 ppm(a)\n0.8 mg/m(3)(b)\n\nSkin Designation\n-\nGlycerin (Mist)\nCAS NO(f): 56-81-5\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nGlycidol\nCAS NO(f): 556-52-5\n\nTransitional Limits: PEL*\n50 ppm(a)\n150 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n25 ppm(a)\n75 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nGlycol monoethyl ether; see 2-Ethoxyethanol\n\nGrain dust (oat, wheat, barley)\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nGraphite, natural respirable dust\nCAS NO(f): 7782-42-5\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nGraphite, synthetic\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nGuthion (R); see Azinphos methyl\n\nGypsum\nCAS NO(f): 13397-24-5\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nHafnium\nCAS NO(f): 7440-58-6\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nHeptachlor\nCAS NO(f): 76-44-8\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nHeptane (n-Heptane)\nCAS NO(f): 142-82-5\n\nTransitional Limits: PEL*\n500 ppm(a)\n2000 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n400 ppm(a)\n1600 mg/m(3)(b)\nSTEL(c)\n500 ppm(a)\n2000 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nHexachlorobutadiene\nCAS NO(f): 87-68-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.02 ppm(a)\n0.24 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nHexachlorocyclo-pentadiene\nCAS NO(f): 77-47-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.01 ppm(a)\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nHexachloroethane\nCAS NO(f); 67-72-1\n\nTransitional Limits: PEL*\n1 ppm(a)\n10 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n1 ppm(a)\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nHexachloronaphthalene\nCAS NO(f): 1335-87-1\n\nTransitional Limits: PEL*\n-\n0.2 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nHexafluoracetone\nCAS NO(f): 684-16-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.7 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nn-Hexane\nCAS NO(f): 110-54-3\n\nTransitional Limits: PEL*\n500 ppm(a)\n1800 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n180 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nHexane isomers\nCAS NO(f): Varies With Compound\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n500 ppm(a)\n1800 mg/m(3)(b)\nSTEL(c)\n1000 ppm(a)\n3600 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\n2-Hexanone (Methyl n-butyl ketone)\nCAS NO(f): 591-78-6\n\nTransitional Limits: PEL*\n100 ppm(a)\n410 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n20 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nHexone (Methyl isobutyl ketone)\nCAS NO(f): 108-10-1\n\nTransitional Limits: PEL*\n100 ppm(a)\n410 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n205 mg/m(3)(b)\nSTEL(c)\n75 ppm(a)\n300 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nsec-Hexyl acetate\nCAS NO(f): 108-84-9\n\nTransitional Limits: PEL*\n50 ppm(a)\n300 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n300 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nHexylene glycol\nCAS NO(f): 107-41-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n25 ppm(a)\n125 mg/m(3)(b)\n\nSkin Designation\n-\nHydrazine\nCAS NO(f): 302-01-2\n\nTransitional Limits: PEL*\n1 ppm(a)\n1.3 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nHydrogenated terphenyls\nCAS NO(f): 61788-32-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nHydrogen bromide\nCAS NO(f): 10035-10-6\n\nTransitional Limits: PEL*\n3 ppm(a)\n10 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n3 mg/m(3)(b)\n10 mg/m(3)(b)\n\nSkin Designation\n-\nHydrogen chloride\nCAS NO(f): 7647-01-0\n\nTransitional Limits: PEL*\n(C) 5 ppm(a)\n(C) 7 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n5 ppm(a)\n7 mg/m(3)(b)\n\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Hydrogen cyanide\nCAS NO(f): 74-90-8\n\nTransitional Limits: PEL*\n10 ppm(a)\n11 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n4.7 ppm(a)\n5 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nHydrogen fluoride (as F)\nCAS NO(f): 7664-39-3\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n3 ppm(a)\n-\nSTEL(c)\n6 ppm(a)\n-\nCEILING\n-\n-\nSkin Designation\n-\nHydrogen peroxide\nCAS NO(f): 7722-84-1\n\nTransitional Limits: PEL*\n1 ppm(a)\n1.4 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n1.4 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nHydrogen selenide (as Se)\nCAS NO(f): 7783-07-5\n\nTransitional Limits: PEL*\n0.05 ppm(a)\n0.2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.05 ppm(a)\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nHydrogen sulfide\nCAS NO(f): 7783-06-4\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nTbl. Z-2\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n14 mg/m(3)(b)\nSTEL(c)\n15 ppm(a)\n21 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nHydroquinone\nCAS NO(f): 123-31-9\n\nTransitional Limits: PEL*\n-\n2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n2-Hydroxypropyl acrylate\nCAS NO(f): 999-61-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n3 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nIndene\nCAS NO(f): 95-13-6\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n45 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nIndium and compounds (as in)\nCAS NO(f): 7440-74-6\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nIodine\nCAS NO(f): 7553-56-2\n\nTransitional Limits: PEL*\n(C) 0.1 ppm(a)\n(C) 1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.1 ppm(a)\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Iodoform\nCAS NO(f): 75-47-8\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.6 ppm(a)\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nIron oxide fume (as Fe)\nCAS NO(f): 1309-37-1\n\nTotal Particulate\n\nTransitional Limits: PEL*\n-\n10 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nIron pentacarbonyl (as Fe)\nCAS NO(f): 13463-40-6\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.8 mg/m(3)(b)\nSTEL(c)\n0.2 ppm(a)\n1.6 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nIron salts (Soluable) (as Fe)\nCAS NO(f): Varies With Compound\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nIsomyl acetate\nCAS NO(f): 123-92-2\n\nTransitional Limits: PEL*\n100 ppm(a)\n525 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n525 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nIsomyl alcohol (primary and\nsecondary)\nCAS NO(f): 123-51-3\n\nTransitional Limits: PEL*\n100 ppm(a)\n360 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n360 mg/m(3)(b)\nSTEL(c)\n125 ppm(a)\n450 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nIsobutyl acetate\nCAS NO(f): 110-19-0\n\nTransitional Limits: PEL*\n150 ppm(a)\n700 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n150 ppm(a)\n700 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nIsobutyl alcohol\nCAS NO(f): 78-83-1\n\nTransitional Limits: PEL*\n100 ppm(a)\n300 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n150 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nIsooctyl alcohol\nCAS NO(f): 26952-21-6\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n\nFinal Rule Limits**: TWA\n50 ppm(a)\n270 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nIsophorone\nCAS NO(f): 78-59-1\n\nTransitional Limits: PEL*\n25 ppm(a)\n140 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n4 ppm(a)\n23 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nIsophorone diisocyanate\nCAS NO(f): 4098-71-9\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.005 ppm(a)\n-\nSTEL(c)\n0.02 ppm(a)\n-\nCEILING\n-\n-\nSkin Designation\nX\n2-Isopropoxyethanol\nCAS NO(f): 109-59-1\n\nTransitional Limits: PEL*\nSkin Designation\n-\nFinal Rule Limits**: TWA\n25 ppm(a)\n105 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nIsopropyl acetate\nCAS NO(f): 108-21-4\n\nTransitional Limits: PEL*\n250 ppm(a)\n950 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n250 ppm(a)\n950 mg/m(3)(b)\nSTEL(c)\n310 ppm(a)\n1185 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nIsopropyl alcohol\nCAS NO(f): 67-63-0\n\nTransitional Limits: PEL*\n400 ppm(a)\n980 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n400 ppm(a)\n980 mg/m(3)(b)\nSTEL(c)\n500 ppm(a)\n1225 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nIsopropylamine\nCAS NO(f): 75-31-0\n\nTransitional Limits: PEL*\n5 ppm(a)\n12 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n12 mg/m(3)(b)\nSTEL(c)\n10 ppm(a)\n24 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nN-Isopropylaniline\nCAS NO(f): 768-52-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nIsopropyl ether\nCAS NO(f): 108-20-3\n\nTransitional Limits: PEL*\n500 ppm(a)\n2100 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n500 ppm(a)\n2100 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nIsopropyl glycidyl ether (IGE)\nCAS NO(f): 4016-14-2\n\nTransitional Limits: PEL*\n50 ppm(a)\n240 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n240 mg/m(3)(b)\nSTEL(c)\n75 ppm(a)\n360 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nKaolin\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nKetene\nCAS NO(f): 463-51-4\n\nTransitional Limits: PEL*\n0.5 ppm(a)\n0.9 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n0.9 mg/m(3)(b)\nSTEL(c)\n1.5 ppm(a)\n3 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nLead inorganic (as Pb)\nCAS NO(f): 7439-92-1\nsee 1910.1025\n\nLimestone\nCAS NO(f): 1317-65-3\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nLindane\nCAS NO(f): 58-89-9\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nLithium hydride\nCAS NO(f): 7580-67-8\n\nTransitional Limits: PEL*\n-\n0.025 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.025 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nL.P.G. (Liquified petroleum gas)\nCAS NO(f): 68476-85-7\n\nTransitional Limits: PEL*\n1000 ppm(a)\n1800 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n1800 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMagnesite\nCAS NO(f): 546-93-0\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMagnesium oxide fume\nCAS NO(f): 1309-48-4\n\nTotal Particulate\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMalathion\nCAS NO(f): 121-75-5\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nMaleic anhydride\nCAS NO(f): 108-31-6\n\nTransitional Limits: PEL*\n0.25 ppm(a)\n1 mg/m(3)(b)\n\nFinal Rule Limits**: TWA\n0.25 ppm(a)\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nManganese compounds (as Mn)\nCAS NO(f): 7439-96-5\n\nTransitional Limits: PEL*\n-\n(C) 5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Manganese fume (as Mn)\nCAS NO(f): 7439-96-5\n\nTransitional Limits: PEL*\n-\n(C) 5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n3 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Manganese cyclopetadienyl tricarbonyl (as\n\nMn)\nCAS NO(f): 12079-65-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nManganese tetroxide (as Mn)\nCAS NO(f): 1317-35-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMarble\nCAS NO(f): 1317-65-3\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMercury (aryl and inorganic) (as Hg)\nCAS NO(f): 7439-97-6\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\nX\nMercury (organo) alkyl compounds (as\n\nHg)\nCAS NO(f): 7439-97-6\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.01 mg/m(3)(b)\nSTEL(c)\n-\n0.03 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nMercury (vapor) (as Hg)\nCAS NO(f): 7439-97-6\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.05 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nMesityl oxide\nCAS NO(f): 141-79-7\n\nTransitional Limits: PEL*\n25 ppm(a)\n100 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n15 ppm(a)\n60 mg/m(3)(b)\nSTEL(c)\n25 ppm(a)\n100 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nMethacrylic acid\nCAS NO(f): 79-41-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n20 ppm(a)\n70 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nMethanethiol; see Methyl mercaptan\n\nMethomyl (Lannate)\nCAS NO(f): 16752-77-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMethoxychlor\nCAS NO(f): 72-43-5\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n2-Methoxyethanol; see Methyl cellosolve\n4-Methoxyphenol\nCAS NO(f): 150-76-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMethyl acetate\nCAS NO(f): 79-20-9\n\nTransitional Limits: PEL*\n200 ppm(a)\n610 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n610 mg/m(3)(b)\nSTEL(c)\n250 ppm(a)\n760 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nMethyl acetylene (Propyne)\nCAS NO(f): 74-99-7\n\nTransitional Limits: PEL*\n1000 ppm(a)\n1650 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n1650 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMethyl acetylene propadiene mixture\n(MAPP)\n\nTransitional Limits: PEL*\n1000 ppm(a)\n1800 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n1800 mg/m(3)(b)\nSTEL(c)\n1250 ppm(a)\n2250 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nMethyl acrylate\nCAS NO(f): 96-33-3\n\nTransitional Limits: PEL*\n10 ppm(a)\n35 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n10 ppm(a)\n35 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nMethylacrylonitrile\nCAS NO(f): 126-98-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n3 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nMethyial (Dimethoxy-methane)\nCAS NO(f): 109-87-5\n\nTransitional Limits: PEL*\n1000 ppm(a)\n3100 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n3100 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMethyl alcohol\nCAS NO(f): 67-56-1\n\nTransitional Limits: PEL*\n200 ppm(a)\n260 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n260 mg/m(3)(b)\nSTEL(c)\n250 ppm(a)\n325 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nMethylamine\nCAS NO(f): 74-89-5\n\nTransitional Limits: PEL*\n10 ppm(a)\n12 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n12 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMethyl amyl alcohol; see Methyl Isobutyl carbinol\n\nMethyl n-amyl ketone\nCAS NO(f): 110-43-0\n\nTransitional Limits: PEL*\n100 ppm(a)\n465 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n465 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMethyl bromide\nCAS NO(f): 74-83-9\n\nTransitional Limits: PEL*\n(C) 20 ppm(a)\n(C) 80 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n5 ppm(a)\n20 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nFootnote (C) denotes a ceiling\nlimit. Methyl butyl ketone; see 2-Hexanone\n\nMethyl cellosolve (2-Methoxyethanol)\nCAS NO(f): 109-86-4\n\nTransitional Limits: PEL*\n25 ppm(a)\n80 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n25 ppm(a)\n80 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nMethyl cellosolve acetate (2-Methoxyethyl\nacetate)\nCAS NO(f): 110-49-6\n\nTransitional Limits: PEL*\n25 ppm(a)\n120 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n25 ppm(a)\n120 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nMethyl chloride\nCAS NO(f): 74-87-3\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nFinal Rule Limits**: TWA\n50 ppm(a)\n105 mg/m(3)(b)\nSTEL(c)\n100 ppm(a)\n210 mg/m(3)(b)\nCEILING\n-\nSkin Designation\n\nMethyl chloroform\n(1,1,1-Trichloroethane)\nCAS NO(f): 71-55-6\n\nTransitional Limits: PEL*\n350 ppm(a)\n1900 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n350 ppm(a)\n1900 mg/m(3)(b)\nSTEL(c)\n450 ppm(a)\n2450 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nMethyl 2-cyanoacrylate\nCAS NO(f): 137-05-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n8 mg/m(3)(b)\nSTEL(c)\n4 ppm(a)\n16 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nMethylcyclohexane\nCAS NO(f): 108-87-2\n\nTransitional Limits: PEL*\n500 ppm(a)\n2000 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n400 ppm(a)\n1600 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMethylcyclohexanol\nCAS NO(f): 25639-42-3\n\nTransitional Limits: PEL*\n100 ppm(a)\n470 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n235 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\no-Methylcyclohexanone\nCAS NO(f): 583-60-8\n\nTransitional Limits: PEL*\n100 ppm(a)\n460 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n50 ppm(a)\n230 mg/m(3)(b)\nSTEL(c)\n75 ppm(a)\n345 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nMethylcyclopentiadienyl manganese tricarbonyl\n(as Mn)\nCAS NO(f): 12108-13-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nMethyl demeton\nCAS NO(f): 8022-00-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\n4,42-Methylene bis (2-chloroaniline)\n(MBOCA)\nCAS NO(f): 101-14-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.02 ppm(a)\n0.22 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\nSkin Designation\nX\nMethylene bis\n(4-cyclohexylisocyanate)\nCAS NO(f): 5124-30-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.01 ppm(a)\n0.11 mg/m(3)(b)\n\nSkin Designation\nX\nMethylene chloride\nCAS NO(f): 75-09-2\n\nTransitional Limits: PEL*\nTbl. Z-2\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\nTbl. Z-2\n-\nSTEL(c)\n\nTbl. Z-2\n-\nCEILING\nTbl. Z-2\n-\nSkin Designation\n-\nMethyl ethyl ketone peroxide (MEKP)\nCAS NO(f): 1338-23-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.7 ppm(a)\n5 mg/m(3)(b)\n\nSkin Designation\n-\nMethyl formate\nCAS NO(f): 107-31-3\n\nTransitional Limits: PEL*\n100 ppm(a)\n250 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n250 mg/m(3)(b)\nSTEL(c)\n150 ppm(a)\n375 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nMethyl hydrazine (Monomethyl\nhydrazine)\nCAS NO(f): 60-34-4\n\nTransitional Limits: PEL*\n(C) 0.2 ppm(a)\n(C) 0.35 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.2 ppm(a)\n0.35 mg/m(3)(b)\n\nSkin Designation\nX\nFootnote (C) denotes a ceiling\nlimit. Methyl iodide\nCAS NO(f): 74-88-4\n\nTransitional Limits: PEL*\n5 ppm(a)\n28 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n2 ppm(a)\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nMethyl isoamyl ketone\nCAS NO(f): 110-12-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n240 mg/m(3)(b)\nSTEL(c)\n-\nCEILING\n-\nSkin Designation\n-\nMethyl isobutyl carbinol\nCAS NO(f): 108-11-2\n\nTransitional Limits: PEL*\n25 ppm(a)\n100 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n25 ppm(a)\n100 mg/m(3)(b)\nSTEL(c)\n40 ppm(a)\n165 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nMethyl isobutyl ketone; see Hexone\n\nMethyl isocyanate\nCAS NO(f): 624-83-9\n\nTransitional Limits: PEL*\n0.02 ppm(a)\n0.05 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n0.02 ppm(a)\n0.05 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nMethyl isopropyl ketone\nCAS NO(f): 563-80-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n705 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMethyl mercaptan\nCAS NO(f): 74-93-1\n\nTransitional Limits: PEL*\n(C) 10 ppm(a)\n(C) 20 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Methyl methacrylate\nCAS NO(f): 80-62-2\n\nTransitional Limits: PEL*\n100 ppm(a)\n410 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n410 mg/m(3)(b)\nSTEL(c)\n-\nCEILING\n-\n-\nSkin Designation\n-\nMethyl parathion\nCAS NO(f): 298-00-0\n\nTransitional Limits: PEL*\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\nSTEL(c)\n-\nCEILING\n-\nSkin Designation\nX\nMethyl propyl ketone; see 2-Pentanone\n\nMethyl silicate\nCAS NO(f): 681-84-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n6 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nalpha-Methyl styrene\nCAS NO(f): 98-83-9\n\nTransitional Limits: PEL*\n(C) 100 ppm(a)\n(C) 480 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n240 mg/m(3)(b)\nSTEL(c)\n100 ppm(a)\n485 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Methylene bisphenyl isocyanate (MDI)\nCAS NO(f): 101-68-8\n\nTransitional Limits: PEL*\n(C) 0.02 ppm(a)\n(C) 0.2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.02 ppm(a)\n0.2 mg/m(3)(b)\n\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. Metribuzin\nCAS NO(f): 21087-64-9\n\nTransitional Limits: PEL*\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMica; see Silicates\n\nMolybdenum (as Mo)\nCAS NO(f): 7439-98-7\n\nSoluble compounds\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nInsoluble Compounds-total dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMonocrotophos (Azodrin (R))\nCAS NO(f): 6923-22-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.25 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nMonomethyl aniline\nCAS NO(f): 100-61-8\n\nTransitional Limits: PEL*\n2 ppm(a)\n9 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nMorpholine\nCAS NO(f): 110-91-8\n\nTransitional Limits: PEL*\n20 ppm(a)\n70 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n20 ppm(a)\n70 mg/m(3)(b)\nSTEL(c)\n30 ppm(a)\n105 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nNaphtha (Coal tar)\nCAS NO(f): 8030-30-6\n\nTransitional Limits: PEL*\n100 ppm(a)\n400 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n400 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nNaphthalene\nCAS NO(f): 91-20-3\n\nTransitional Limits: PEL*\n10 ppm(a)\n50 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n50 mg/m(3)(b)\nSTEL(c)\n15 ppm(a)\n75 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nalpha-Naphthylamine; CAS NO(f): 134-32-7\nsee 1910.1004\nbeta-Naphthylamine; CAS NO(f): 91-59-8\nsee 1910.1009\n\nNickel carbonyl (as Ni)\nCAS NO(f): 13463-39-3\n\nTransitional Limits: PEL*\n0.001 ppm(a)\n0.007 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.001 ppm(a)\n0.007 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nNickel, metal and insoluble compounds (as\n\nNi)\nCAS NO(f): 7440-02-0\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nNickel, insoluble compounds (as Ni)\nCAS NO(f): 7440-02-0\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nNicotine\nCAS NO(f): 54-11-5\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nNitric acid\nCAS NO(f): 7697-37-2\n\nTransitional Limits: PEL*\n2 ppm(a)\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n5 mg/m(3)(b)\nSTEL(c)\n4 ppm(a)\n10 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nNitric oxide\nCAS NO(f): 10102-43-9\n\nTransitional Limits: PEL*\n25 ppm(a)\n30 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n25 ppm(a)\n30 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\np-Nitroaniline\nCAS NO(f): 100-01-6\n\nTransitional Limits: PEL*\n1 ppm(a)\n6 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n3 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nNitrobenzene\nCAS NO(f): 98-95-3\n\nTransitional Limits: PEL*\n1 ppm(a)\n5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n1 ppm(a)\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\nSkin Designation\nX\np-Nitrochlorobenzene\nCAS NO(f): 100-00-5\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\nSkin Designation\nX\n4-Nitrodiphenyl; CAS NO(f): 92-93-3\nsee 1910.1003\n\nNitroethane\nCAS NO(f): 79-24-3\n\nTransitional Limits: PEL*\n100 ppm(a)\n310 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n310 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nNitrogen dioxide\nCAS NO(f): 10102-44-0\n\nTransitional Limits: PEL*\n(C) 5 ppm(a)\n(C) 9 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n1 ppm(a)\n1.8 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (C) denotes a ceiling limit. Nitrogen trifluoride\nCAS NO(f): 7783-54-1\n\nTransitional Limits: PEL*\n10 ppm(a)\n29 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n29 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nNitroglycerin(1)\nCAS NO(f): 55-63-0\n\nTransitional Limits: PEL*\n(C) 0.2 ppm(a)\n(C) 2 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n0.1 mg/m(3)(b)(l)\nCEILING\n-\n-\nSkin Designation\nX\nFootnote (C) denotes a ceiling\nlimit. Footnote (1) The Final Rule Limit STEL\nof 0.1 mg/m(3) is not in effect as a result of reconsideration for the\nindustrial sector of civilian manufacture and distribution of explosives and\npropellants for civilian use. The Final rule limits skin designation and the\n\nTransitional limits ceiling limit of 2 mg/m(3) remains in effect for this\nsector until completion of the reconsideration. Nitromethane\nCAS NO(f): 75-52-5\n\nTransitional Limits: PEL*\n100 ppm(a)\n250 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n250 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n1-Nitropropane\nCAS NO(f): 108-03-2\n\nTransitional Limits: PEL*\n25 ppm(a)\n90 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n25 ppm(a)\n90 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n2-Nitropropane\nCAS NO(f): 79-46-9\n\nTransitional Limits: PEL*\n25 ppm(a)\n90 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n35 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nN-Nitrosodimethylamine; CAS NO(f): 62-79-9\nsee 1910.1016\n\nNitrotoluene\nCAS NO(f): o-isomer 88-72-2; m-isomer\n99-08-1; p-isomer 99-99-0\n\nTransitional Limits: PEL*\n5 ppm(a)\n30 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n2 ppm(a)\n11 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nNitrotrichloromethane; see\n\nChloropicrin\n\nNonane\nCAS NO(f): 111-84-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n1050 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nOctachloronaphthalene\nCAS NO(f): 2234-13-1\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n0.3 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nOctane\nCAS NO(f): 111-65-9\n\nTransitional Limits: PEL*\n500 ppm(a)\n2350 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n300 ppm(a)\n1450 mg/m(3)(b)\nSTEL(c)\n375 ppm(a)\n1800 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nOil mist, mineral\nCAS NO(f): 8012-95-1\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nOsmium tetroxide (as Os)\nCAS NO(f): 20816-12-0\n\nTransitional Limits: PEL*\n-\n0.002 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.0002 ppm(a)\n0.002 mg/m(3)(b)\nSTEL(c)\n0.0006 ppm(a)\n0.006 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nOxalic acid\nCAS NO(f): 144-62-7\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n2 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nOxygen difluoride\nCAS NO(f): 7783-41-7\n\nTransitional Limits: PEL*\n0.05 ppm(a)\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.05 ppm(a)\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nOzone\nCAS NO(f): 10028-15-6\n\nTransitional Limits: PEL*\n0.1 ppm(a)\n0.2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.2 mg/m(3)(b)\nSTEL(c)\n0.3 ppm(a)\n0.6 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nParaffin wax fume\nCAS NO(f): 8002-74-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nParaquat, respirable dust\nCAS NO(f): 1910-42-5; 2074-50-2; 4685-14-7\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nParathion\nCAS NO(f): 56-38-2\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nParticulates not otherwise regulated\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\nSkin Designation\n-\nPentaborane\nCAS NO(f): 19624-22-7\n\nTransitional Limits: PEL*\n0.005 ppm(a)\n0.01 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.005 ppm(a)\n0.01 mg/m(3)(b)\nSTEL(c)\n0.015 ppm(a)\n0.03 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nPentachloronaphthalene\nCAS NO(f): 1321-64-8\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nPentachlorophenol\nCAS NO(f): 87-86-5\n\nTransitional Limits: PEL*\n-\n0.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nPentaerythritol\nCAS NO(f): 115-77-5\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPentane\nCAS NO(f): 109-66-0\n\nTransitional Limits: PEL*\n1000 ppm(a)\n2950 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n600 ppm(a)\n1800 mg/m(3)(b)\nSTEL(c)\n750 ppm(a)\n2250 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\n2-Pentanone (Methyl propyl ketone)\nCAS NO(f): 107-87-9\n\nTransitional Limits: PEL*\n200 ppm(a)\n700 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n700 mg/m(3)(b)\nSTEL(c)\n250 ppm(a)\n875 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nPentachloronaphthalene\n(Tetrachloroethylene)\nCAS NO(f): 127-18-4\n\nTransitional Limits: PEL*\nTbl. Z-2\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n25 ppm(a)\n170 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPerchloromethyl mercaptan\nCAS NO(f): 594-42-3\n\nTransitional Limits: PEL*\n0.1 ppm(a)\n0.8 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.8 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPerchloryl fluoride\nCAS NO(f): 7616-94-6\n\nTransitional Limits: PEL*\n3 ppm(a)\n13.5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n3 ppm(a)\n14 mg/m(3)(B)\nSTEL(c)\n6 ppm(a)\n28 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nPerlite\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n* Petroleum distillates (Naphtha) (Rubber\n\nSolvent)\n\nTransitional Limits: PEL*\n500 ppm(a)\n2000 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n400 ppm(a)\n1600 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPhenol\nCAS NO(f): 108-95-2\n\nTransitional Limits: PEL*\n5 ppm(a)\n19 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n5 ppm(a)\n19 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nPhenothiazine\nCAS NO(f): 92-84-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\np-Phenylene diamine\nCAS NO(f): 106-50-3\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nPhenyl ether, vapor\nCAS NO(f): 101-84-8\n\nTransitional Limits: PEL*\n1 ppm(a)\n7 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n7 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPhenyl ether-biphenyl mixture, vapor\n\nTransitional Limits: PEL*\n1 ppm(a)\n7 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n7 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPhenylethylene; see Styrene\n\nPhenyl glycidyl ether (PGE)\nCAS NO(f): 122-60-1\n\nTransitional Limits: PEL*\n10 ppm(a)\n60 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n6 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPhenylhydrazine\nCAS NO(f): 100-63-0\n\nTransitional Limits: PEL*\n5 ppm(a)\n22 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n5 ppm(a)\n20 mg/m(3)(b)\nSTEL(c)\n10 ppm(a)\n45 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nPhenyl mercaptan\nCAS NO(f): 108-98-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPhenylphosphine\nCAS NO(f): 638-21-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.05 ppm(a)\n0.25 mg/m(3)(b)\n\nSkin Designation\n-\nPhorate\nCAS NO(f): 298-02-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.05 mg/m(3)(b)\nSTEL(c)\n-\n0.2 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nPhosdrin (Mevinphos (R))\nCAS NO(f): 7786-34-7\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n0.01 ppm(a)\n0.1 mg/m(3)(b)\nSTEL(c)\n0.03 ppm(a)\n0.3 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nPhosgene (Carbonyl chloride)\nCAS NO(f): 75-44-5\n\nTransitional Limits: PEL*\n0.1 ppm(a)\n0.4 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.4 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPhosphine\nCAS NO(f): 7803-51-2\n\nTransitional Limits: PEL*\n0.3 ppm(a)\n0.4 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.3 ppm(a)\n0.4 mg/m(3)(b)\nSTEL(c)\n1 ppm(a)\n1 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nPhosphoric acid\nCAS NO(f): 7664-38-2\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n3 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nPhosphorus (yellow)\nCAS NO(f): 7723-14-0\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPhosphorous oxychloride\nCAS NO(f): 10025-87-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.6 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPhosphorus pentachloride\nCAS NO(f): 10026-13-8\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPhosphorus pentasulfide\nCAS NO(f): 1314-80-3\n\nTransitional Limits: PEL*\n1 mg/m(3)(b)\n\nSkin designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n3 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nPhosphorus trichloride\nCAS NO(f): 7719-12-2\n\nTransitional Limits: PEL*\n0.5 ppm(a)\n3 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.2 ppm(a)\n1.5 mg/m(3)(b)\nSTEL(c)\n0.5 ppm(a)\n3 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nPhthalic anhydride\nCAS NO(f): 85-44-9\n\nTransitional Limits: PEL*\n2 ppm(a)\n12 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n6 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nm-Phthalodinitrile\nCAS NO(f): 626-17-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPictoram\nCAS NO(f): 1918-02-1\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPicric acid\nCAS NO(f): 88-89-1\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nPiperazine dihydro-chloride\nCAS NO(f): 142-64-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPindone (2-Pivalyl-1,3-indandione)\nCAS NO(f): 83-26-1\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPlaster of paris\nCAS NO(f): 26499-65-0\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPlatinum (as Pt)\nCAS NO(f): 7440-06-4\n\nMetal\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSoluble Salts\n\nTransitional Limits: PEL*\n-\n0.002 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.002 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPortland cement\nCAS NO(f): 65997-15-1\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits **: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPotassium hydroxide\nCAS NO(f): 1310-58-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n-\n2 mg/m(3)(b)\n\nSkin Designation\n-\nPropane\nCAS NO(f): 74-98-6\n\nTransitional Limits: PEL*\n1000 ppm(a)\n1800 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n1800 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\nSkin Designation\n-\nPropargyl alcohol\nCAS NO(f): 107-19-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nbeta-Propriolactone; CAS NO(f): 57-57-8\nsee 1910.1013\n\nPropionic acid\nCAS NO(f): 79-09-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n30 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPropoxur (Baygon)\nCAS NO(f): 114-26-1\n\nTransitonal Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nn-Propyl acetate\nCAS NO(f): 109-60-4\n\nTransitional Limits: PEL*\n200 ppm(a)\n840 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n840 mg/m(3)(b)\nSTEL(c)\n250 ppm(a)\n1050 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nn-Propyl alcohol\nCAS NO(f): 71-23-8\n\nTransitional Limits: PEL*\n200 ppm(a)\n500 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n500 mg/m(3)(b)\nSTEL(c)\n250 ppm(a)\n625 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nn-Propyl nitrate\nCAS NO(f): 627-13-4\n\nTransitional Limits: PEL*\n25 ppm(a)\n110 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n25 ppm(a)\n105 mg/m(3)(b)\nSTEL(c)\n40 ppm(a)\n170 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nPropylene dichloride\nCAS NO(f): 78-87-5\n\nTransitional Limits: PEL*\n75 ppm(a)\n350 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n75 ppm(a)\n350 mg/m(3)(b)\nSTEL(c)\n110 ppm(a)\n510 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nPropylene glycol dinitrate\nCAS NO(f): 6423-43-4\n\nTransitional Limits: PEL*\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.05 ppm(a)\n0.8 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPropylene glycol monomethyl ether\nCAS NO(f): 107-98-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n360 mg/m(3)(b)\nSTEL(c)\n150 ppm(a)\n540 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nPropylene imine\nCAS NO(f): 75-55-8\n\nTransitional Limits: PEL*\n2 ppm(a)\n5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n2 ppm(a)\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nPropylene oxide\nCAS NO(f): 75-56-9\n\nTransitional Limits: PEL*\n100 ppm(a)\n240 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n20 ppm(a)\n50 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPropyne; see Methyl acetylene\n\nPyrethrum\nCAS NO(f): 8003-34-7\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n-\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nPyridine\nCAS NO(f): 110-86-1\n\nTransitional Limits: PEL*\n5 ppm(a)\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nQuinone\nCAS NO(f): 106-51-4\n\nTransitional Limits: PEL*\n0.1 ppm(a)\n0.4 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.4 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nResorcinol\nCAS NO(f): 108-46-3\n\nTransitional Limits: PEL*\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n45 mg/m(3)(b)\nSTEL(c)\n20 ppm(a)\n90 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nRhodium (as Rh), metal fume and insoluble\ncompounds\nCAS NO(f): 7440-16-6\n\nTransitional Limits: PEL*\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\nSkin Designation\n-\nRhodium (as Rh), soluble compounds\nCAS NO(f): 7440-16-6\n\nTransitional Limits: PEL*\n-\n0.001 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.001 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRonnel\nCAS NO(f): 299-84-3\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRosin core solder pyrolysis products, as\nformaldehyde\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRotenone\nCAS NO(f): 83-79-4\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRouge\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSelenium compounds (as Se)\nCAS NO(f): 7782-49-2\n\nTransitional Limits: PEL*\n-\n0.2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSelenium hexafluoride (as Se)\nCAS NO(f): 7783-79-1\n\nTransitional Limits: PEL*\n0.05 ppm(a)\n0.4 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.05 ppm(a)\n0.4 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSilica, amorphous, precipitated and\ngel\nCAS NO(f): 112926-00-8\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n6 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSilica, amorpous, diatomaceous earth, containing\nless than 1% cyrstalline silica\nCAS NO(f): 61790-53-2\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n6 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n* Silica, crystalline cristobalite, respirable\ndust\nCAS NO(f): 14464-46-1\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.05 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n* Silica, crystalline quartz, respirable\ndust\nCAS NO(f): 14808-60-7\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSilica, crystalline tripoli (as quartz), respirable dust\nCAS NO(f): 1317-95-9\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n* Silica, crystalline tridymite, respirable\ndust\nCAS NO(f): 15468-32-3\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.05 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSilica, fused, respirable dust\nCAS NO(f): 60676-86-0\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSilicates (less than 1% crystalline\nsilica CAS NO(f): 12001-26-2\n\nMica (respirable dust)\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n3 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSoapstone, Total Dust\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n6 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSoapstone, Respirable Dust\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n3 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n\nTalc (containing asbestos): use asbestos\nlimit: See 29 CRF 1910.1001\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: Talc (containing no asbestos), respirable\ndust CAS NO(f): 14807-96-6\n\nTransitional Limits: PEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTremolite\n\nTransitional Limits: See 29 CFR\n1010.1101\nPEL*\n-\nTbl. Z-3\n\nSkin Designation\n-\nFinal Rule Limits**: Silicon\nCAS NO(f): 7440-21-3\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSilicon carbide\nCAS NO(f): 409-21-2\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSilicon tetrahydride\nCAS NO(f): 7803-62-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n7 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSilver, metal and soluble compounds (as\n\nAg)\nCAS NO(f): 7440-22-4\n\nTransitional Limits: PEL*\n-\n0.01 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.01 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSoapstone; see Silicates\n\nSodium azide (as HN (3)): CAS NO(f): 26628-22-8\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.1 ppm(a)\n-\nSkin Designation\nX\n(as NaN (3)): Transitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n-\n0.3 mg/m(3)(b)\n\nSkin Designation\nX\nSodium bisulfite\nCAS NO(f): 7631-90-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSodium fluoroacetate\nCAS NO(f): 62-74-8\n\nTransitional Limits: PEL*\n-\n0.05 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.05 mg/m(3)(b)\nSTEL(c)\n-\n0.15 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\nX\nSodium hydroxide\nCAS NO(f): 1310-73-2\n\nTransitional Limits: PEL*\n-\n2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n-\n2 mg/m(3)(b)\n\nSkin Designation\n-\nSodium metabisulfite\nCAS NO(f): 7681-57-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nStarch\nCAS NO(f): 9005-25-8\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nStibine CAS\nNO(f): 7803-52-3\n\nTransitional Limits: PEL*\n0.1 ppm(a)\n0.5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.1 ppm(a)\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nStoddard solvent\nCAS NO(f): 8052-41-3\n\nTransitional Limits: PEL*\n500 ppm(a)\n2900 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n525 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nStrychnine\nCAS NO(f): 57-24-9\n\nTransitional Limits: PEL*\n-\n0.15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nStyrene\nCAS NO(f): 100-42-5\n\nTransitional Limits: PEL*\nTbl. Z-2\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n215 mg/m(3)(b)\nSTEL(c)\n100 ppm(a)\n425 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nSubtilisins (Proteolytic enzymes)\nCAS NO(f): 9014-01-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n0.00006 mg/m(3)(b) (60 min.) (g)\nCEILING\n-\n-\nSkin Designation\n\nFootnote (g) Compliance with the\nsubtilisins PEL is assessed by sampling with a high volume sampler (600-800\nliters per minute) for at least 60 minutes. Sucrose\nCAS NO(f): 57-50-1\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSulfur dioxide\nCAS NO(f): 7446-09-5\n\nTransitional Limits: PEL*\n5 ppm(a)\n13 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n5 mg/m(3)(b)\n*STEL(c)\n5 ppm(a)\n13 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nSulfur hexafluoride\nCAS NO(f): 2551-62-4\n\nTransitional Limits: PEL*\n1000 ppm(a)\n6000 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n6000 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSulfuric acid\nCAS NO(f): 7664-93-9\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSulfur monochloride\nCAS NO(f): 10025-67-9\n\nTransitional Limits: PEL*\n1 ppm(a)\n6 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n1 ppm(a)\n6 mg/m(3)(b)\n\nSkin Designation\n-\nSulfur pentafluoride\nCAS NO(f): 5714-22-7\n\nTransitional Limits: PEL*\n0.025 ppm(a)\n0.25 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.01 ppm(a)\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nSulfur tetrafluoride\nCAS NO(f): 7783-60-0\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.1 ppm(a)\n0.4 mg/m(3)(b)\n\nSkin Designation\n-\nSulfuryl fluoride\nCAS NO(f): 2699-79-8\n\nTransitional Limits: PEL*\n5 ppm(a)\n20 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n20 mg/m(3)(b)\nSTEL(c)\n10 ppm(a)\n40 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nSulprofos\nCAS NO(f): 35400-43-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nSystox (R); see Demeton\n2,4,5-T\nCAS NO(f): 93-76-5\n\nTransitional Limits: PEL*\n-\n10 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTalc; see Silicates\n\nTantalum, metal and oxide dust\nCAS NO(f): 7440-25-7\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTEDP (Sulfotep)\nCAS NO(f): 3689-24-5\n\nTransitional Limits: PEL*\n-\n0.2 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nTellurium and compounds (as Te)\nCAS NO(f): 13494-80-9\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTellurium hexafluoride (as Te)\nCAS NO(f): 7783-80-4\n\nTransitional Limits: PEL*\n0.02 ppm(a)\n0.2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.02 ppm(a)\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTemephos\nCAS NO(f): 3383-96-8\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTEPP\nCAS NO(f): 107-49-3\n\nTransitional Limits: PEL*\n-\n0.05 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.05 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nTerphenylis\nCAS NO(f): 26140-60-3\n\nTransitional Limits: PEL*\n(C) 1 ppm(a)\n(C) 9 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n0.5 ppm(a)\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit. 1,1,1,2-Tetrachloro-2,2-difluoroethane\nCAS NO(f): 76-11-9\n\nTransitional Limits: PEL*\n500 ppm(a)\n4170 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n500 ppm(a)\n4170 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n1,1,2,2-Tetrachloro-1,2-difluoroethane\nCAS NO(f): 76-12-0\n\nTransitional Limits: PEL*\n500 ppm(a)\n4170 mg/mm(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n500 ppm(a)\n4170 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n1,1,2,2-Tetrachloroethane\nCAS NO(f): 79-34-5\n\nTransitional Limits: PEL*\n5 ppm(a)\n35 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n1 ppm(a)\n7 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nTetrachlorethylene; see Perchloroethylene\n\nTetrachloromethane; see Carbon tetrachloride\n\nTetrachloronaphthalene\nCAS NO(f): 1335-88-2\n\nTransitional Limits: PEL*\n-\n2 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nTetraethyl lead (as Pb)\nCAS NO(f): 78-00-2\n\nTransitional Limits: PEL*\n-\n0.075 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.075 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nTetrahydrofuran\nCAS NO(f): 109-99-9\n\nTransitional Limits: PEL*\n200 ppm(a)\n590 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n200 ppm(a)\n590 mg/m(3)(b)\nSTEL(c)\n250 ppm(a)\n735 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nTetramethyl lead, (as Pb)\nCAS NO (f): 75-74-1\n\nTransitional Limits: PEL*\n-\n0.075 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.075 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nTetramethyl succinonitrile\nCAS NO (f): 3333-52-6\n\nTransitional Limits: PEL*\n0.5 ppm(a)\n3 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n0.5 ppm(a)\n3 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nTetranitromethane\nCAS NO (f): 509-14-8\n\nTransitional Limits: PEL*\n1 ppm(a)\n8 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n8 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTetrasodium pyrophosphate\nCAS NO (f): 7722-88-5\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTetryl\n(2,4,6-Trinitro-phenyl-methyl-nitramine)\nCAS NO (f): 479-45-8\n\nTransitional Limits: PEL*\n-\n1.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n1.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nThallium, soluble compounds (as Tl)\nCAS NO (f): 7440-28-0\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\n4,42-Thiobis (6-tert, Butyl-m-cresol)\nCAS NO (f): 96-69-5\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nThioglycolic acid\nCAS NO (f): 68-11-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n4 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nThionyl chloride\nCAS NO (f): 7719-09-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n1 ppm(a)\n5 mg/m(3)(b)\n\nSkin Designation\n-\nThiram\nCAS NO (f): 137-26-8\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTin, inorganic compounds (except oxides) (as\n\nSn)\nCAS NO (f): 7440-31-5\n\nTransitional Limits: PEL*\n-\n2 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTin, organic compounds (as Sn)\nCAS NO (f): 7440-31-5\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nTin oxide (as Sn)\nCAS NO (f): 21651-19-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTitanium dioxide\nCAS NO (f): 13463-67-7\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nToluene\nCAS NO (f): 108-88-3\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n375 mg/m(3)(b)\nSTEL(c)\n150 ppm(a)\n560 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nToluene-2,4-diisocyanate (TDI)\nCAS NO (f): 584-84-9\n\nTransitional Limits: PEL*\n(C) 0.02 ppm(a)\n(C) 0.14 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.005 ppm(a)\n0.04 mg/m(3)(b)\nSTEL(c)\n0.02 ppm(a)\n0.15 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation. Footnote (C) denotes a ceiling\nlimit. m-Toluidine\nCAS NO (f): 108-44-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n9 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\no-Toluidine\nCAS NO (f): 95-53.4\n\nTransitional Limits: PEL*\n5 ppm(a)\n22 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n5 ppm(a)\n22 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\np-Toluidine\nCAS NO (f): 106-49-0\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n9 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nToxaphene; see Chlorinated camphene\n\nTremolite; see Silicates\n\nTributyl phosphate\nCAS NO (f): 126-73-8\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.2 ppm(a)\n2.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTrichloroacetic acid\nCAS NO (f): 76-03-9\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n7 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n1,2,4-Trichlorobenzene\nCAS NO (f): 120-82-1\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n5 ppm(a)\n40 mg/m(3)(b)\n\nSkin Designation\n-\n1,1,1-Trichloroethane; see Methyl chloroform\n1,1,2-Trichloroethane\nCAS NO (f): 79-00-5\n\nTransitional Limits: PEL*\n10 ppm(a)\n45 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n10 ppm(a)\n45 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nTrichloroethylene\nCAS NO (f): 79-01-6\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nTbl. Z-2\n\nSkin Designation\n\nThl. Z-2\n\nFinal Rule Limits**: TWA\n50 ppm(a)\n270 mg/m(3)(b)\nSTEL(c)\n200 ppm(a)\n1080 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nTrichloromethane; see Chloroform\n\nTrichloronaphthalene\nCAS NO (f): 1321-65-9\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\n1,2,3-Trichloropropane\nCAS NO (f): 96-18-4\n\nTransitional Limits: PEL*\n50 ppm(a)\n300 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n60 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n1,1,2-Trichloro-1,2,2-trifluoroethane\nCAS NO (f): 76-13-1\n\nTransitional Limits: PEL*\n1000 ppm(a)\n7600 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n7600 mg/m(3)(b)\nSTEL(c)\n1250 ppm(a)\n9500 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nTriethylamine\nCAS NO (f): 121-44-8\n\nTransitional Limits: PEL*\n25 ppm(a)\n100 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n40 mg/m(3)(b)\nSTEL(c)\n15 ppm(a)\n60 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nTrifluorobromomethane\nCAS NO (f): 75-63-8\n\nTransitional Limits: PEL*\n1000 ppm(a)\n6100 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1000 ppm(a)\n6100 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTrimellitic anhydride\nCAS NO (f): 552-30-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n0.005 ppm(a)\n0.04 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTrimethylamine\nCAS NO (f): 75-50-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n24 mg/m(3)(b)\nSTEL(c)\n15 ppm(a)\n36 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nTrimethyl benzene\nCAS NO (f): 25551-13-7\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n25 ppm(a)\n125 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTrimethyl phosphite\nCAS NO (f): 121-45-9\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n2 ppm(a)\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\n2,4,6-Trinitrophenyl; see Picric acid\n2,4,6-Trinitrophenylmethyl\nnitramine; see Tetryl\n2,4,6-Trinitrotoluene (TNT)\nCAS NO (f): 118-96-7\n\nTransitional Limits: PEL*\n-\n1.5 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n-\n0.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nTriorthocresyl phosphate\nCAS NO (f): 78-30-8\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nTriphenyl amine\nCAS NO (f): 603-34-9\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTriphenyl phosphate\nCAS NO (f): 115-86-6\n\nTransitional Limits: PEL*\n-\n3 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n3 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nTungsten (as W)\nCAS NO (f): 7440-33-7\n\nInsoluble Compounds\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n10 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nSoluble Compounds\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n3 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nTurpentine\nCAS NO (f): 8006-64-2\n\nTransitional Limits: PEL*\n100 ppm(a)\n560 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n560 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nUranium (as U)\nCAS NO (f): 7440-61-1\n\nSoluble Compounds\n\nTransitional Limits: PEL*\n-\n0.05 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.05 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nInsoluble Compounds\n\nTransitional Limits: PEL*\n-\n0.25 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.2 mg/m(3)(b)\nSTEL(c)\n-\n0.6 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nn-Valeraldehyde\nCAS NO (f): 110-62-3\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n50 ppm(a)\n175 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nVanadium\nCAS NO (f): 1314-62-1\n\nRespirable dust (as V(2)O(5))\n\nTransitional Limits: PEL*\n-\n(C) 0.5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.05 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFume (as V(2)O(5))\n\nTransitional Limits: PEL*\n-\n(C) 0.1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.05 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFootnote (C) denotes a ceiling\nlimit\n\nVegetable oil mist\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n15 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nVinyl acetate\nCAS NO (f): 108-05-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n30 mg/m(3)(b)\nSTEL(c)\n20 ppm(a)\n60 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nVinyl benzene; see Styrene\n\nVinyl bromide\nCAS NO (f): 593-60-2\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n5 ppm(a)\n20 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nVinyl chloride; see 1910.1017\nCAS NO (f): 75-01-4\n\nVinyl cyanide*; see Acrylonitrile\n\nVinyl cyclohexene dioxide\nCAS NO (f): 106-87-6\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n10 ppm(a)\n60 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nVinylidene chloride\n(1,1-Dichloroethylene)\nCAS NO (f): 75-35-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n1 ppm(a)\n4 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nVinyl toluene\nCAS NO (f): 25013-15-4\n\nTransitional Limits: PEL*\n100 ppm(a)\n480 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n480 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nVM & P Naphtha\nCAS NO (f): 8032-32-4\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n300 ppm(a)\n1350 mg/m(3)(b)\nSTEL(c)\n400 ppm(a)\n1800 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nWarfarin\nCAS NO (f): 81-81-2\n\nTransitional Limits: PEL*\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n0.1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nWelding fumes (total particulate***) (As\ndetermined from breathing-zone air samples)\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nFootnote*** As determined from\nbreathing-zone air samples. Wood dust, all soft and hard woods, except Western red cedar\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n10 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nWood dust, Western red cedar\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n2.5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nXylenes (o-, m-, p-isomers)\nCAS NO(f): 1330-20-7\n\nTransitional Limits: PEL*\n100 ppm(a)\n435 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n100 ppm(a)\n435 mg/m(3)(b)\nSTEL(c)\n150 ppm(a)\n655 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nm-Xylene alpha, alpha2-diamine\nCAS NO(f): 1477-55-0\n\nTransitional Limits: PEL*\n-\n-\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\nX\nXylidine\nCAS NO(f): 1300-73-8\n\nTransitional Limits: PEL*\n5 ppm(a)\n25 mg/m(3)(b)\n\nSkin Designation\nX\nFinal Rule Limits**: TWA\n2 ppm(a)\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\nX\nYttrium\nCAS NO(f): 7440-65-5\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nZinc chloride fume\nCAS NO(f): 7646-85-7\n\nTransitional Limits: PEL*\n-\n1 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n1 mg/m(3)(b)\nSTEL(c)\n-\n2 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nZinc chromate (as CrO (3))\nCAS NO(f): Varies with Compound\n\nTransitional Limits: PEL*\nTbl. Z-2\n\nTbl. Z-2\n\nSkin Designation\n\nTbl. Z-2\n\nFinal Rule Limits**: TWA\n-\n-\nSTEL(c)\n-\n-\nCEILING\n-\n0.1 mg/m(3)(b)\n\nSkin Designation\n-\nZinc oxide fume\nCAS NO (f): 1314-13-2\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n10 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nZinc oxide\nCAS NO (f): 1314-13-2\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nZinc stearate\nCAS NO (f): 557-05-1\n\nTotal Dust\n\nTransitional Limits: PEL*\n-\n15 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n10 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nRespirable fraction\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n-\nCEILING\n-\n-\nSkin Designation\n-\nZirconium compounds (as Zr)\nCAS NO (f): 7440-67-7\n\nTransitional Limits: PEL*\n-\n5 mg/m(3)(b)\n\nSkin Designation\n-\nFinal Rule Limits**: TWA\n-\n5 mg/m(3)(b)\nSTEL(c)\n-\n10 mg/m(3)(b)\nCEILING\n-\n-\nSkin Designation\n-\nTABLE Z-2\n\nAcceptable max. peak above the\nacceptable ceil. concentration for an 8-hr shift\n\nMaterial\n8-hour time-wtd\n\nAverage\n\nAcceptable ceiling\nconcentration\n\nConcentration\n\nMaximum duration\n*Benzene (Z37.40-1969)(a)\n10 ppm\n25 ppm\n50 ppm\n10 minutes\n\nBeryllium and Berylium compounds (Z37.29-1970)\n2 ug/m(3)\n5 ug/m(3)\n25 ug/m(3)\n30 minutes\n*Cadmium fume (Z37.5-1970)(c)\n0.1 mg/m(3)\n0.3 mg/m(3)....... Cadmium dust (Z37.5-1970)(c)\n0.2 mg/m(3)\n0.6 mg/m(3)....... Carbon disulfide (Z37.3-1968)\n20 ppm\n30 ppm\n100 ppm\n30 minutes\n\nCarbon Tetrachloride (Z37.17-1967)\n10 ppm\n25 ppm\n200 ppm\n5 min. in any 4 hrs. Chromic acid and chromates (Z37-7-1971)....... 1 mg/10 m(3)....... Ethylene dibromide (Z37.31-1970)\n20 ppm\n30 ppm\n50 ppm\n5 minutes\n\nEthylene dichloride (Z37.21-1969)\n50 ppm\n100 ppm\n200 ppm\n5 min. in any 3 hrs. Formaldehyde (Z37.16-1967)(b)\n3 ppm\n5 ppm\n10 ppm\n30 minutes\n\nHydrogen fluoride (Z37.28-1969)\n3 ppm.............. Hydrogen sulfide (Z37.2-1966)....... 20 ppm\n50 ppm\n10 minutes once only if no other meas. exposure\noccurs\n\nFluoride as dust (Z37.38-1969)\n2.5 mg.m(3).............. Mercury (Z237.8-1971)....... 1 mg/10 m(3)....... Methyl chloride (Z37.18-1969)\n100 ppm\n200 ppm\n300 ppm\n5 min. in any 3 hrs. Methylene chloride (Z37.23-1969)\n500 ppm\n1,000 ppm\n2,000 ppm\n5 min. in any 2 hrs. Organo (alkyl) mercury (Z37.30-1969)\n0.01 mg/m(3)\n0.04 mg/m(3)....... Styrene (Z37.15-1969)\n100 ppm\n200 ppm\n600 ppm\n5 min. in any 3 hrs. Tetrachloroethylene (Z37.22-1967)\n100 ppm\n200 ppm\n300 ppm\n5 min. in any 3 hrs. Toluene (Z37.12-1967)\n200 ppm\n300 ppm\n500 ppm\n10 minutes\n\nTrichloroethylene (Z37.19-1967)\n100 ppm\n200 ppm\n300 ppm\n5 min in any 2 hrs. *The transitional PELs are 8-hour TWAs unless otherwise\nnoted; a (C) designation denotes a ceiling limit. ** Unless otherwise noted, employers in General Industry\n(\ni.e., those covered by 29 CFR\n1910\n) may use any combination\nof controls to achieve these limits until December 31, 1993 as set forth in\n29 CFR\n1910.1000(f). *** As determined from breathing zone air samples. a\n\nParts of vapor or gas per\nmillion parts of contaminated air by volume at 25 degrees C abd 760\ntorr. b\n\nMilligrams of substance per\ncubic meter of air. When a numeric entry for a substance is in the mg/m(3)\ncolumn and not in the ppm column, then the number in the mg/m(3) column is\nexact. When numerical entries for a substance are in both the ppm and mg/m(3)\ncolumns, then the number in the mg/m(3) column may be rounded off. c\n\nDuration is for 15 minutes, unless otherwise noted. d\n\nThe final benzene standard in\n1910,.1028 applies to all occupational exposures to benzene except some\nsubsegments of industry where exposures are consistenly under the action level\n(i.e., distribution and sale of fuels, sealed containers and pipelines, coke\nproduction, oil and gas drilling and production, natural gas processing, and\nthe percentage exclusion for liquid mixtures); for the excepted subsegments, the benzene limits in Table Z-2 apply. TABLE Z-3\n\nMineral Dusts\n\nSubstance\nmppcf(e)\nmg/m(3)\nSILICA: 250(f)\n10 mg/\nCRYSTALLINE\nm(3)(m)\nQUARTZ (RESPIRABLE)....... QUARTZ (TOTAL DUST)....... %SiO(2) +5\n%SiO(2) +2\n30 mg/m(3)\n%SiO(2) +2\nCRYSTOBALITE: Use 1/2 the value calculated from the\ncount or mass formulae for quartz\nTRIDYMITE: Use 1/2 the value calculated from the\nformulae for quartz\nAMORPHOUS, including natural diatomaceous earth....... 20\n80 mg/m(3)\n%SiO(2)\nSILICATES (less than 1% crystaline silica): Mica....... 20....... Soapstone....... 20....... Talc (not containing asbestos)....... 20(n)....... Talc (containing asbestos). Use asbestos limit\n\nTremolite (see 29 CFR\n1910.1101\n)\n\nPortland cement....... 50....... GRAPHITE (NATURAL)....... 15....... COAL DUST (respirable fraction less than 5% SiO(2)....... 2.4 mg/m(3)\nor\n\nFor more than 5% SiO(2)....... 10 mg/m(3)\n%SiO(2) +2\n* INERT OR NUISANCE DUST(G): Respirable fraction....... 15\n5 mg/m(3)\n\nTotal dust....... 50\n15 mg/m(3)\n\nNote - Conversion factors - mppcf X 35.3 = million\nparticles per cubic meter = particles per c.c. *This standard applies to the industry segments exempt from\nthe 1 ppm 8-hour TWA and 5 ppm STEL of the benzene standard at\n1910.1028. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 12\nยง\n800.5\n\nAmended\n\nNew\n\nYork State Register December 13, 2023/Volume XLV, Issue 50, eff. 12/13/2023\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 43085
}